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Eukaryotic DNA is found packaged with proteins and RNA, which forms
a substance called chromatin. This packaging is dynamic and regulates
access to DNA for essential cellular processes such as transcription,
replication, and repair. In recent years, studies have shown that regulated
changes in the chemical and physical properties of chromatin often lead to
dynamic changes in multiple cellular processes by affecting the accessibility
of the DNA. These changes can be brought about in part through posttranslational modifications of histone proteins, which are involved in
disrupting chromatin contacts or by recruiting effector proteins to chromatin.
Acetylation is one of the well-studied post-translational modifications
that has been associated with chromatin-associated processes, notably gene
regulation. Many studies have contributed to our knowledge of the
enzymology underlying acetylation, including efforts to understand the
molecular mechanism of substrate recognition by several acetyltransferases,
but traditional experiments to determine intrinsic features of substrate and
site specificity have proven challenging. In my thesis work, I hypothesize
that the primary amino acid sequence surrounding an acetylated lysine plays
a critical role in acetylation site selection, and whether there are sequence
preferences that enable a lysine acetyltransferase to recognize target

lysines. A computational method was devised to examine this hypothesis,
and an experimental approach was taken to test my computationally-derived
predictions. In Chapter 2, I describe my basic computational methods, using
a clustering analysis of protein sequences to predict lysine acetylation based
on the sequence characteristics of acetylated lysines within histones. I define
a

local

amino

acid

sequence

composition

that

represents

potential

acetylation sites by implementing a clustering analysis of histone and nonhistone sequences. I demonstrate that this sequence composition has
predictive power on two independent experimental datasets of acetylation
marks. In Chapter 3, I describe the experimental validation approach used
to detect acetylation in histone and nonhistone proteins using mass
spectrometry. I also report several novel non-histone acetylated substrates
in S. cerevisiae. My approach, combined with more traditional experimental
methods, may be useful for identifying additional proteins in the acetylome.
Finally, in Chapter 4, I describe two bioinformatics approaches; one to
predict additional chromatin associated effector proteins, and another to
further understand the evolutionary history and complexity of the Polycomb
Group (PcG) proteins in multicellular organisms in order to infer gene
expansion, co-evolution, and deletion events.
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Chapter 1: General Introduction
The annotated human genome contains approximately 40,000 genes by
current estimates (Karolchik, Baertsch et al. 2003), a number that seems
surprisingly low. However, the estimated number of proteins encoded by
these genes is two to three orders of magnitude higher (Hsu, Pringle et al.
2005). Because each protein is generally encoded by one gene in the
genome, one might expect a one to one correspondence of genes to
proteins. However, this is not the case: the estimated number of proteins
encoded by the 40,000 human genes is two to three orders of magnitude
higher. What is the purpose of this diversity? Proteome complexity can be
built by diversification at both the mRNA level (through alternative splicing)
and the protein level (through post-translational modification (PTM) of the
protein side chains). Greater than 5% of the genes in the human genome
encode enzymes that catalyze such modifications, including hundreds of
protein kinases, phosphatases, ubiquitiyl ligases, acetylases and
deacetylases, methyl transferases and glycosyl transferases. By adding
chemical moieties onto one or more amino acids, PTMs can determine a
protein’s localization, interactions with other proteins, and gene expression.
For example, phosphorylation of a protein substrate can propagate
downstream signaling events (Burnett and Kennedy 1954; Olsen, Blagoev et
al. 2006), ubiquitination marks cyclins and other proteins for degradation at
cell-cycle specific time points (Xu, Duong et al. 2009), and methylation can
1

epigenetically activate (Beisel, Imhof et al. 2002) or repress gene expression
(Nakayama, Rice et al. 2001; Grewal and Rice 2004).
PTMs are particularly abundant and well studied in histone proteins,
the major protein components of chromatin. Chromatin is the coupling of
DNA, RNA, and protein that make up chromosomes. The nucleosome, the
fundamental repeating unit of chromatin, consists of 146 base pairs of DNA
wrapped around the four core histones (H2A, H2B, H3, H4)(Luger, Mader et
al. 1997) (Figures 1.1A, B). Multiple nucleosomes joined by stretches of
linker DNA form a structure known as “beads on a string” (Figure 1.1B).
We are only beginning to understand that the changes in chromatin
structure that underlie many DNA-templated processes are affected by posttranslational modification of histone proteins, including but not limited to
methylation, phosphorylation, and acetylation (Figure 1.1C). These
modifications may contribute to “epigenetic signatures” that are important
for diverse processes such as gene regulation, apoptosis, mitosis, and
responses to DNA damage. These modifications create a dynamic readout,
referred to as the “histone code” (Strahl and Allis 2000; Turner 2008),
where PTMs can function as binding sites for specific protein domains while
other PTMs alter the net charge on the nucleosomes in a way that alters
chromatin structure.

2

Figure 1.1: Chromatin organization and post-translational modifications
A. A nucleosome particle is composed of 146 bp of DNA wrapped around an octamer of 2
copies each of histones H2A, H2B, H3, and H4, with the tails of the histone proteins
protruding from the core structure. These particles are then linked together by the DNA to
form a structure known as “beads on a string”. Image modified from (Marmorstein 2001).
B. Crystal structure of nucleosome solved at 2.8Å. Nucleosome core particle: ribbon traces
for the 146-bp DNA (Watson strand and Crick strands in brown and turquoise, respectively)
and eight histone protein main chains (blue: H3; green: H4; yellow: H2A; red: H2B). Image
adapted from (Luger, Mader et al. 1997).
C. Shown are the four core histones: H3, H4, H2A, and H2B, and their post-translational
modification sites. Acetylation marks are denoted by red filled circles, arginine methylation
denoted by yellow hexagons, and lysine methylation denoted by green or red hexagons. For
lysine methylation sites, green hexagons denote active marks (such as H3K4me) while red
hexagons denote repressive marks, (such as H3K27). Green circles are phosphorylationa nd
blue ovals are ubiquitylation. Boxes surrounding H3, H4, H2A, and H2B represent histone
globular domains. Image modified from Epigenetics, 2007.
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Figure 1.1
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Histone Acetylation
More than forty years ago, Allfrey and colleagues reported a strong
correlation between increased levels of histone acetylation and elevated
levels of gene expression (Allfrey, Faulkner et al. 1964). Since then, the
field of chromatin biology has advanced considerably with remarkable
progress made into mechanistic insights of histone modifications and their
biological functions. Histone acetylation has the capacity to destabilize the
chromatin polymer through neutralization of the basic charge of the lysine
residue, potentially with consequences for chromatin nucleosomal stability
and higher-order structure (“cis” effects) (Tse, Sera et al. 1998; Verreault,
Kaufman et al. 1998; Taverna, Li et al. 2007). Furthermore, acetylation can
potentially affect chromatin dynamics by recruiting specialized “effector”
proteins (“trans”-effects) (Jenuwein and Allis 2001).
Lysine acetylation in histones was the first PTM for which the enzymes
that both catalyze HATs (histone acetyltransferases) and remove HDACs
(histone deacetylases) was identified. These enzymes are responsible for
governing a steady-state balance of acetylation (Brownell, Zhou et al. 1996;
Taunton, Hassig et al. 1996; Pflum, Tong et al. 2001). In fact, the first
transcription-related nuclear histone acetyltransferase (HAT, or KAT
renamed in (Allis, Berger et al. 2007)), Gcn5, was isolated from the
Tetrahymena macronucleus through an in-gel assay (a mixture of proteins
5

from cell extracts separated on a SDS gel) (Brownell, Zhou et al. 1996).
Since then, the discovery of KAT proteins acetylating all four core histones
has been a hallmark for the chromatin field as researchers have studied the
individual modifications and their functional relevance in the cell (Kurdistani,
Tavazoie et al. 2004; Shogren-Knaak, Ishii et al. 2006; Kaplan, Liu et al.
2008; Li, Zhou et al. 2008; Tjeertes, Miller et al. 2009)(Figure 1.2A; in
red). In addition to the discovery of the first transcription-related histone
KAT, the discovery of the first transcription related histone HDAC, HDAC1,
(Taunton, Hassig et al. 1996) also led to the formation of a model for genespecific histone PTMs: activators that are bound by DNA are involved in
recruiting KATs to acetylate nucleosomal histones, while repressors recruit
HDACs to deacetylate histones. Three years later, the first bromodomain
was discovered as a protein that interacts specifically with acetylated lysines
in histones (Dhalluin, Carlson et al. 1999), making it the first known protein
module to do so. Bromodomains were functionally linked to the HAT activity
of co-activators in the regulation of gene transcription. Together, modifying
enzymes that “write” the PTM, enzymes that “erase” the PTM, and molecules
that interact specifically with the PTM or “readers”, are linked to enzyme
activity in gene expression regulation, but how do these molecules recognize
their epitopes, and what dictates their recognition machinery? Primary
sequence context surrounding a target lysine could be one major factor
dictating these types of recognition (Figure 1.2B), however this factor is
6

still relatively understudied. Limited biochemical and structural studies of
KATs and bromodomain coupled to histones display some sequence
preferences (Mujtaba, Zeng et al. 2007; Liu, Wang et al. 2008), however a
rigorous and thorough analysis is still needed to pinpoint specific sequence
motifs or patterns on the substrate that help establish appropriate
acetyllysine-dependent interactions with chromatin.

7

Figure 1.2: Histone Acetylation Function and Primary Sequence Context
A. Acetylation marks are denoted by red circles. Functions associated with the acetyl marks
are shown by a rectangular box. Image modified from Epigenetics,2007.
B. Lysine in center (red) and letters (in black) surrounding lysine represent the primary
sequence context of a PTM. Effector (in green) also can bind the modification based on
contacts it makes with residues surrounding the PTM.
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Figure 1.2
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Structural analyses of KATs coupled to histone tail peptides have been
the subject of intense study. KAT enzymes catalyze the transfer of an acetyl
group from the co-factor acetyl-Coenzyme A (acetyl-CoA) to the -amine of
a substrate lysine side chain. A large number of KATs have now been
identified and characterized. Studies on the divergent histone KAT enzymes
Gcn5/PCAF, Esa1 and Hat1 have provided insights into the underlying
mechanism of acetylation by KAT proteins (Marmorstein 2001; Marmorstein
and Roth 2001). These three histone KAT enzymes contain a conserved core
domain that plays a role in binding the co-factor acetyl-CoA in catalysis.
More recently, biochemical and structural studies of the metazoan-specific
p300/CBP (human homolog of Gcn5) and fungal-specific Rtt109 histone
KATs have provided a new understanding into the evolutionary and ancestral
relationship between histone KATs and their divergent catalytic and
substrate-binding properties (Wang, Tang et al. 2008).
Co-crystallized histone KATs coupled to peptides also provide insight
regarding substrate recognition. Positively charged residues are typically
present within three to four amino acid residues (about 10 Å) upstream or
downstream of the acetylated lysine residues of known p300 (a human
homolog of Gcn5)/CBP substrates (Wang, Tang et al. 2008). Moreover, the
X-ray crystal structure of p300, in complex with a bi-substrate inhibitor, LysCoA reveals the preference for nearby basic residues, such as a lysine in the
+2 and -2 positions (Wang, Tang et al. 2008). Specificity for a random-coil
10

structure containing a G-K-X-P recognition sequence on the histone
substrate is revealed the when the Gcn5 crystal structure is coupled to the
H31-20 peptide (Rojas, Trievel et al. 1999; Liu, Wang et al. 2008) (Figure
1.3). Critical contacts between Gcn5 and H3K14 are displayed; the glycines
(G13), and proline (P15) preceding and following H3 lysine 14 make the
tightest contacts with Gcn5 and suggest residues that are specific to Gcn5
recognition.

Other nonhistone Gcn5-mediated substrates also possess a

similar G-K-X-P pattern and will be described further in Chapter 3. These
studies demonstrate that residues in the core domain of the KAT together
with proximal residues surrounding acetyl-lysines on the histone substrate
can help achieve substrate specificity (Liu, Wang et al. 2008).
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Figure 1.3: Gcn5 (a histone KAT) coupled to histone H3 peptide and coenzyme A
(CoA)
Solvent accessible surface representation of Tetrahymena GCN5 HAT domain coupled to
Histone H31-20 peptide (in yellow) and CoA (shown clearer in enlarged box; bottom). Red
box (bottom) represents an enlarged view of the Gcn5 HAT domain in contact with the
H3S10-P16 residues of the peptide represented by a stick model. CoA is shown on bottom
right. Note that G12 and P16 make direct contacts with the catalytic domain. Image
provided by A. Ruthenburg.
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Nonhistone protein acetylation and methods in detecting acetylated
substrates
To a lesser extent, nonhistone protein acetylation has also been implicated
in a wide variety of biological processes, such as DNA binding or the
stabilization of multi-subunit complexes (Glozak, Sengupta et al. 2005)
(Sterner and Berger 2000; Yang and Seto 2008). One of the most famous
nonhistone proteins that was discovered as acetylated was p53, where
pioneering studies by Roeder and colleagues demonstrated that p53
acetylation was critical for the regulation of its binding to the DNA (Figure
1.4A,B) (Gu and Roeder 1997). Since then, KATs, such as p300, have been
shown to acetylate multiple other nonhistone transcription-related proteins.
Additional studies have identified additional acetylated proteins, such as
HIV1 integrase (Cereseto, Manganaro et al. 2005), an HIV protein whose
acetylation is required for its viral integration. Acetylation of alpha tubulin
was also recently shown to be critical for the formation of cortical neurons in
the developing mouse brain (Wynshaw-Boris 2009). Intriguingly, several
transcription factors, such as E2F1, and MYC implicated in cancer pathways,
have also been shown to be acetylated (Sterner and Berger 2000; Ozaki,
Okoshi et al. 2009).
Conventional experiments, such as mutagenesis of potential acetylated
lysines, acetylation-specific antibodies, metabolic labeling, mass
13

spectrometry (MS), and in-vitro histone acetyltransferase assays (Figure
1.4C) have typically been used in order to identify acetylated lysines in
substrate proteins. More recently, large scale proteomic studies have
emerged as a result of high- throughput technology. In one study, the KAT
NuA4 (the essential nucleosome acetyltransferase of H4) was incubated with
yeast proteome microarrays in the presence of radioactive acetyl-CoA. Many
non-chromatin substrates of complex were identified and validated, including
acetylation (Lys19 and Lys514) of phosphoenolpyruvate carboxykinase
(Pck1p). Acetylation at these sites was then shown to be important for
yeast glucogenesis (Lin, Lu et al. 2009). Additionally, advanced proteomic
tools have enabled identification of several hundred acetylation sites in
approximately two hundred proteins, using samples derived from HeLa cells,
mouse liver and bacteria (Kim, Sprung et al. 2006). In addition to regulators
of chromatin-based cellular processes, non-nuclear proteins with diverse
functions were also identified. Most strikingly, acetylated lysines were found
in more than 20% of mitochondrial proteins, including many metabolic
enzymes (Kim, Sprung et al. 2006). Another high resolution mass
spectrometry study published recently revealed that lysine acetylation
preferentially targets large macromolecular complexes involved in diverse
cellular processes, such as chromatin remodeling, cell cycle, splicing, nuclear
transport, and actin nucleation. The study also reveals that acetylation
substrates had enriched residues flanking the target lysine depending on
14

whether the protein resided in the nuclear, cytoplasm, or mitochondria
compartment in the cell (Choudhary, Kumar et al. 2009).

15

Figure 1.4: Examples of nonhistone protein acetylation
A. p53 was one of the first nonhistone acetylated proteins discovered via radioactive
labeling (Gu and Roeder 1997). The protein (total of 393 amino acids) is heavily acetylated
protein in the C-terminal tail. Eight lysines have have been identified as acetylated via mass
spectrometry, immunoblotting, and mutagenesis experiments. p53 acetylation stimulates
sequence specific DNA binding activity in vivo and in vitro and increases stability of protein.
B. A histone KAT can also acetylate lysines in nonhistone proteins. p53 is a classic example,
where p300 ( the histone KAT) acetylates multiple residues of p53 as shown in B, but also
lysines in the core histones.
C. Some of the traditional methods used to identify PTMs on histone and nonhistone
proteins. Shown are biochemistry methods, metabolic labeling, site-directed mutagenesis
of potential PTM sites, mass spectrometry, and site specific acetyl antibodies.
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Figure 1.4
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Thus, the discovery of acetylation on histone and nonhistone proteins
has been a key advancement in the chromatin field, and has allowed for a
better understanding of the roles acetylation plays in human biology and
disease. Promising advances have been made in the treatment of certain
cancers by developing drug therapies that target HDACs (Marks 2007).
While knowing which amino acids in the proteome are acetylated has clear
biological and disease applications, currently, only a subset of the total
acetylated residues in the proteome have been identified. Methods that
allow for rapid identification of all acetylated amino acids in the proteome
would therefore be of great importance to the biological community. A
computational tool that is predictive of acetylation events in histone and
nonhistones could contribute to a more complete understanding of what
substrates are physiologically relevant, as more insights are gained into
acetylation-mediated pathways.
Computational studies
A limited number of studies suggest that there may be sequence recognition
target(s) for certain KATs (Kimura and Horikoshi 1998; Kimura and
Horikoshi 1998). A putative “rule” for lysine selection in a primary sequence
by a KAT has been proposed previously by examining the N-terminal tail of
histones (Kimura and Horikoshi 1998). For example, TIP60 (a mammalian
KAT), recognizes specific glycine-lysine G-K patterns in human proteins in
18

vitro and in vivo (Kimura and Horikoshi 1998). Additionally, the acetylation
of Rch1 (a nuclear importin factor) is severely inhibited when a glycine
adjacent to the modified lysine is mutated, supporting the view that G-K is
part of a recognition motif for acetylation (Bannister, Miska et al. 2000).
Moreover, the KAT CLOCK1, acetylates H3 lysine 14, which bears a similar
sequence environment to the acetylated lysine of the CLOCK-mediated
substrate BMAL1 (Hirayama, Sahar et al. 2007). The term “histone mimic”
was recently put forward to describe short stretches in nonhistone proteins
that closely resemble histone sequences containing PTMs (Sampath, Marazzi
et al. 2007). Observations such as these provide early indications of specific
“rules” that can potentially define enzyme recognition of target substrates.
More recently, a prediction program was published illustrating that
acetylation could be predicted via an analysis of lysine acetylation motifs in a
large human proteome-wide dataset (Schwartz, Chou et al. 2009). These
motifs were scanned against proteomic sequence data using a newly
developed tool called scan-x to globally predict other potential modification
sites within multiple organisms. Ten-fold cross-validation was used to
determine the sensitivity and minimum specificity for each set of predictions,
where a specificity (proportion of of actual positives which are correctly
identified) 94%, and a sensitivity (proportion of negatives which are
correctly identified) of 17% was achieved. In Chapter 2, I describe a
computational model which I have developed to predict human additional
19

histone and nonhistone substrates in the acetylome. In addition to a
computational approach, I experimentally validated my target predictions in
budding yeast in vivo as described in Chapter 3.
Yeast PTMs and conservation of histones
Histones are among the most highly conserved proteins across species,
allowing for their study in multiple organisms. In particular, acetylation in
budding yeast histones is a well-studied phenomenon. Extensive studies
mapping acetylation and the responsible enzymatic pathways using the
yeast core histones have been performed (Grunstein 1990; Clarke, O'Neill et
al. 1993; Brownell, Zhou et al. 1996; Grant, Duggan et al. 1997; Smith,
Eisen et al. 1998; Bird, Yu et al. 2002). These studies were possible through
traditional biochemical methods (Figure 1.4C) and highly specific antibodies
against histone acetyl-lysines that have been widely used in yeast chromatin
studies (Suka, Suka et al. 2001). Genome wide mapping studies of yeast
acetylation (via ChIP-Chip) illustrate that H3K9ac peaks at the predicted
transcriptional start sites of active genes and that this modification
correlates with transcription rates genome-wide (Figure 1.5A) (Pokholok,
Harbison et al. 2005). Similarly, acetylation of histone H3 at lysine 14 peaks
over the start sites of active genes and correlates with transcription rates
genome-wide.

Additionally, H3K36 was discovered as acetylated (Figure

1.5A) and the pattern of H3K36ac localization is similar to that of other sites
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of H3 acetylation, including H3K9ac and H3K14ac, although the peak of
H3K36me2, a well described PTM in yeast, is within the active gene coding
region (Figure 1.5A) (Morris, Rao et al. 2007). Set2 (KMT3)-dependent
methylation of histone H3 at lysine 36 (H3K36) was also shown to promote
deacetylation and repression (Youdell, Kizer et al. 2008).
Perhaps one of the better described and major acetylation marks in
budding yeast is H3K56, an acetylation mark in the globular domain of H3,
which is critical for the recruitment of the nucleosome remodeling factor
Snf5 and subsequent transcription (Xu, Zhang et al. 2005). These findings
indicated to the chromatin field that histone H3 K56 acetylation enables
recruitment of the SWI/SNF nucleosome remodeling complex to regulate
gene activity. Moreover, H3K56ac has been shown as a DNA-damageresponsive mark, important for genomic stability in mammals (Yuan, Pu et
al. 2009). In addition, acetylation of H3K56 is increased in multiple types of
cancer, correlating with increased levels of ASF1A, a key protein in
nucleosome assembly (Tjeertes, Miller et al. 2009; Yuan, Pu et al. 2009). A
former postdoc in the Allis Lab, Sandra Hake, along with the Don Hunt
laboratory at UVA (Charlottesville, VA), performed an in-depth analysis of
methylation and acetylation profiles of multiple organisms ranging from
Tetrahymena to mammals (Figure 1.5B). Their work illustrates that higher
eukaryotes (multicellular) contain a higher number of methylation or
silencing marks, whereas lower eukaryotes possess more acetylation or
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activation marks (Garcia, Hake et al. 2007). Moreover, within the histone
globular domain, PTMs were far less conserved from unicellular to
multicellular organisms (ie. K56ac), whereas the H3 tail acetylation marks
were more conserved between the two groups (Figure 1.5B) (Garcia, Hake
et al. 2007).
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Figure 1.5: H3 acetylation in yeast and conservation between organisms
A. ChIP study showing that H3K9/K14ac and H3K36ac (black and red curves, respectively)
both peak at transcriptional start sites, whereas K36me2 (blue curve) peaks within active
coding regions. Image modified and chart lines were superimposed due to low figure
quality from (Morris, Rao et al. 2007).
B. Histone H3 modifications detected in MS/MS experiments from human, mouse,
Tetrahymena, and yeast. Acetyl marks are denoted by red circles, and methyl marks are
denoted by green hexagons. Note that histone PTMS in tail region are more conserved in
multicellular species and PTMs in globular region are more conserved in unicellular species.
Image adapted (Garcia, Hake et al. 2007).
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Figure 1.5
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Mutagenesis and crosstalk experiments in yeast
Since yeast is easy to genetically manipulate, many labs including ours have
used it for mutagenesis and functional studies of post-translational
modifications of histones. Groups such as the Michael Grunstein lab have
performed tail deletions of H2A and H2B and swapping experiments of the
H3 and H4 tails in yeast, which resulted in the disrupted regulation of
specific genes as well as silencing of yeast mating type cassettes (Schuster,
Han et al. 1986; Ling, Harkness et al. 1996). More recently, the Shilatifard
group systematically generated a complete library of the alanine
substitutions of all of the residues of the four core histones in S. cerevisiae
(Nakanishi, Sanderson et al. 2008). Several cases where one mark was
required for another on the histone H3 N-terminal tail were identified,
including histone H3K14ac (H3K14ac), a mark which is required for normal
levels of H3K4 trimethylation (Nakanishi, Sanderson et al. 2008). Additional
data on crosstalk, or one mark is required for the presence or absence of
another mark of covalent modifications of histones in yeast reveal that
phosphorylation of serine 10 in histone H3 is functionally linked in vitro and
in vivo to Gcn5-mediated acetylation at H3K14 (Lo, Trievel et al. 2000).
These types of observations suggest that transcriptional regulation can occur
through multiple linked covalent modifications in histones (Lo, Trievel et al.
2000; Strahl and Allis 2000; Latham and Dent 2007) (Figure 1.6A).
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The Boeke laboratory recently created a versatile library of 486
systematic histone H3 and H4 substitution and deletion mutants that probes
the contribution of each residue to nucleosome function. Their findings
suggest that there are surprisingly a few residues essential for cell viability
considering the very well conserved sequences of H3 and H4 among
different organisms. This observation implies a possibility that multiple
residues on histones can function redundantly (Dai, Hyland et al. 2008).
Typically, in order to detect phenotypes and analyze how PTMs can crossregulate one another (as described in the previous section), lysines which
are positively charged, acetylable residues, are mutated to small (uncharged
residues such as alanine or glycine), arginines (positively charged, and
unacetylable), or glutamines (negatively charged, acetyl mimics) (Figure
1.6B). Single lysine mutations have demonstrated phenotypic defects in
yeast, such as H3K36R producing a transcriptional elongation defect
(Carrozza, Li et al. 2005), H3K56R producing genome stability defects,
chromosomal breaks, and cell lifespan reduction (Recht, Tsubota et al. 2006;
Driscoll, Hudson et al. 2007; Dang, Steffen et al. 2009), and H4K16Q
significantly reducing cell lifespan (Dang, Steffen et al. 2009). Multiple
mutations on identical or different histones have also demonstrated
phenotypes, such as H3K56R combined with H4K5,8,12R for replication (Li,
Zhou et al. 2008), and H4K5,8,12,16R for cell viability (Megee, Morgan et al.
1990). While larger mutagenesis studies and screens have focused on
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designing experiments to abrogate levels of specific PTM marks, only a few
studies to my knowledge have been aimed at mutating the surrounding
residues of the target lysine to detect a different PTM than was previously
known, or to observe an increase or decrease of the PTM level of the target
lysine (Bannister, Miska et al. 2000; Nelson, Santos-Rosa et al. 2006). In
my own work described in Chapter 3, I have mutagenized the flanking
residues of H3K14 to in order to determine whether the mutation of its
flanking residues has any effect on H3K14ac levels, or whether mutagenesis
can induce an additional PTM such as methylation.
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Figure 1.6: Crosstalk between lysine methylation and acetylation on H3 and H4
histone tails.
A. Crosstalk between H3K9, H3S10, and H3K14 based on previous literature. The H3
modifications also have an effect on H4K20 methylation (top). H3ac/H4ac crosstalk with
H3K4me (bottom). H3ac/H4ac refer to multiple acetylation sites on H3 and H4. Red circles
represent acetylation marks, green hexagons represent methylation marks, and white
circles represent phosphorylation marks. Image adapted from (Latham and Dent 2007)
B. Lysines (positively charged, acetylable residues) typically mutated into small uncharged
residues (glycine or alanine), charged, unacetylable residues (arginine), and uncharged,
acetyl mimics (glutamines) for phenotypic analysis, PTM detection, or to detect effects on
other modifications.
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In the previous sections, I discussed protein acetylation, focused largely on
histone acetylation “writers”. In the next section, I will next discuss
“readers,” proteins that interact specifically with a PTM and the historic
challenges and methods used to uncover additional domains within these
readers. I will also briefly introduce the domain structure and functional
importance of an array of chromatin-associated proteins.
Domain Prediction Challenges
Domain prediction from primary amino acid sequence has historically been a
challenging task. However, improved domain prediction programs are
enabling high accuracy structure predictions, more directed mutagenesis and
binding studies, and a deeper scope to perform evolutionary analyses. Many
protein motifs characteristically associated with chromatin have been shown
to have affinity for modified histone tails, acting as “effectors” or readers for
histone PTMs, notably lysine acetylation and methylation. These motifs have
been discovered through experimental cloning and in-vitro peptide binding
assays, however since there are multiple modifications on the protein with a
multitude of interaction partners, a number of these effector molecules have
yet to be discovered.

Using domain prediction tools and computational

techniques can thus help us achieve a higher number of chromatin binding
domains that are still undiscovered.

In Chapter 4, I aim to describe the

bioinformatic method I used to predict additional effectors in chromatin
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associated proteins, and present data on the evolutionary domain analysis of
PcG proteins.
Domain definitions and statistical methods used to characterize
domains
To understand the roots of the domain prediction challenge, one needs to
delve deeply into the definition of a domain. Domains are considered to be
the building units of protein structure. A protein can contain a single domain
or multiple domains, each one typically associated with a specific function.
The architecture of a protein’s domain determines the function of the
protein, its subcellular localization and the intermolecular interactions it is
involved in. However, over the years, domains have been defined in several
different ways, each definition focusing on a different aspect of the domain
hypothesis (Ingolfsson and Yona 2008):
-A domain is a protein unit that can fold independently
-It forms a specific fold in 3D space
-It performs a specific task/function
-It is a movable unit that was formed early on in the course of evolution

Most of these definitions are widely accepted, but some are more
subjective than others. For example, the definition of a cluster in 3D space
is dependent on the algorithm and experimental data used to define the
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clusters and the parameters of that algorithm. Furthermore, while the first
two definitions focus on structural aspects, the other definitions do not
necessarily contain a structural constraint. Domain prediction programs
such as SMART and PFAM (Schultz, Milpetz et al. 1998; Finn, Tate et al.
2008) have aimed to overcome these challenges by using statistical
prediction methods. However because the precise definition of domain is
subjective, predicted domains can be missed in these programs largely for a
number of reasons: (1) The protein of interest might contain new domains
that have not been characterized or studied yet, and therefore the protein
might be poorly represented in existing domain databases with limited
information about its domain. For most proteins (and especially newly
sequenced ones) the structure is unknown, thus structure-focused methods
are excluded. (2) Protein should have homologs in order for the prediction
method to be effective. Methods may only work using databases of proteins
containing homology, but not on individual proteins. (3) Existing domain
prediction algorithms can be inconsistent in their domain annotations.
Without accurate structural information, it is difficult to validate the
performance of prediction algorithms. When the structure is known,
determining the constituent domains might not be straightforward
(Ingolfsson and Yona 2008).
Statistical prediction methods have tried to solve the multifaceted
problem of domain prediction by implementing well-constructed multiple
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sequence alignments (MSAs), which are a positive source of information for
domain predictions. These MSAs feed into a statistical model, typically a
Hidden Markov Model (HMM), which computes the probability of a given
sequence by using the consensus MSA to predict additional domains of
interest. MSA alignments are much easier and faster to generate than
three-dimensional models and can thus be used in large-scale domain
predictions. Moreover, MSAs can also be used to detect remote homologies.
On the other hand, sequences that are highly similar usually contain little
information on domain boundaries and bias predictions as they mask other
equally crucial but less represented sequences.
Several atypical or cryptic domains, domains which are dissimilar to
the canonical domain by sequence, yet contain some or all the key residues
are typically needed for the binding surface are often missed by domain
prediction programs. These types of domains are challenging for prediction
algorithms since domains often function through intermolecular interactions
that depend on chemical and structural properties of the interacting surface
that need to be compensated for, and primary amino acid sequence is
insufficient. RAG2 (an essential component of the RAG1/2 V(D)J
recombinase) is an example of a protein that contains a plant homeodomain
(PHD) finger that specifically recognizes histone H3 trimethylated at lysine 4
(H3K4me3) (Matthews, Kuo et al. 2007). Though RAG2 has a conserved
tryptophan that constitutes a key structural component of the K4me333

binding surface and is essential for Rag2's recognition of H3K4me3, the
overall similarity of RAG2’s PHD finger with the canonical domain is only
25% similar by amino acid sequence and therefore is missed by domain
prediction programs. These examples display that with a better training set,
and manipulation of key sequence parameters, we can improve reliability
and the number of predictions generated on single and multidomain
proteins.
While many of the proteins known today contain a single domain, it
has been noted that the majority of proteins contain multiple domains.
Consistent with the evolutionary aspect of the domain hypothesis, more
complex organisms have a higher number of multi-domain proteins (Tordai,
Nagy et al. 2005). Multidomain proteins represent a substantial fraction of
the proteome: about 27% of proteins in bacteria and 39% of proteins in
metazoa are multi-domain proteins (Tordai, Nagy et al. 2005). Multidomain
proteins are structurally (and often functionally) more complex than singledomain proteins, which lends itself to additional complexity at the protein
signaling level.

Multidomains proteins can evolve through gene duplication

and domain shuffling (insertion, deletion, rearrangement, and internal
duplication of domains), which can be caused by duplication and insertion of
a domain into a novel genomic context, tandem duplication of domains,
domain deletion, gene fusion and fission (Song, Sedgewick et al. 2007).
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Chromatin associated domains and importance
A great deal of evidence suggests that PTMs function through the
recruitment of downstream effector proteins, which in turn perform a task
on chromatin (Shi, Hong et al. 2006) (Wysocka, Swigut et al. 2006) (Figure
1.7A). A specific role for post-translational modifications on histones
(histone marks) is to stabilize the binding of effector proteins, which can
influence gene expression by modifying chromatin structure, recruiting the
components of the transcription machinery, or establish additional
modifications (Figure 1.7A).
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Figure 1.7: Effector proteins and cryptic domains
A. Well characterized bromodomain (BD), chromodomain (CD), and PHD finger domains in
histones H3 and H4. Shown is the Drosophila NURF 301 PHD finger bound to H3K4me3, HP1
chromodomain bound to H3K9me, Polycomb (Pc) bound to H3K27me, and the bromodomain
of GCN5 bound to H4K16 in yeast.
B. Multiple sequence alignment of ING2 PHD fingers. Aromatic cage residues, zinc
coordination residues, and histone H3 arginine 2-interacting residues are colored in purple,
red, and orange, respectively. Mouse RAG2 is highlighted (in red box) and displays a cryptic
PHD finger due to the sequence dissimilarity with coordinated Zn and cage residues. Image
adapted from (Ruthenburg, Allis et al. 2007).
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Figure 1.7
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Wysocka et al. show that a plant homeodomain (PHD) finger of nucleosome
remodeling factor (NURF), an ISWI-containing ATP-dependent chromatinremodeling complex, interacts with H3K4me3. When the PHD finger is
deleted in Xenopus, a loss-of-function phenotype is observed, and
compromises spatial control of Hox gene expression (Wysocka, Swigut et al.
2006). Additional PHD finger proteins have more recently been shown to be
implicated in disease, such as MLL (Wang, Song et al. 2009), RAG2
(Matthews, Kuo et al. 2007) (Figure 1.7B; red box), and Kap1 (Zeng, Yap
et al. 2008). Crystal studies of the numerous PHD finger domains coupled to
H3 peptides have revealed high conservation within the domain and an
aromatic cage that is important for histone binding selectivity for H3K4me3.
Moreover, crystal structures of the BPTF PHD finger coupled to the H3
peptide display that the residues in the N-2 and N+2 positions respective to
the H3K4 mark, are often critical determinants of binding specificity
(Taverna, Li et al. 2007).
Another domain of interest is the bromodomain which recognizes
acetylated lysine residues such as those on the N-terminal tails of histones.
Bromodomain binding perpetrates a pivotal mechanism for regulating
protein-protein interactions in histone-directed chromatin remodeling and
gene transcription (Figure 1.7A) (Mujtaba, Zeng et al. 2007). Several
reports indicate that the overall fold of bromodomains is highly conserved,
but the subtle structure of the non-conserved loop region is crucial to their
38

function (Mujtaba, Zeng et al. 2007). The chromodomain which recognizes
methyl-lysines (the most famous being HP1 which binds to H3K9me (Figure
1.7A) is part of the Royal Superfamily of protein folds, which also includes
the Tudor, Chromo barrel, and MBT domains (Taverna, Li et al. 2007). The
HP1 and Polycomb chromodomains, which are similar to the chromodomains
of CDY family proteins, distinguish two methylated lysine residues within
ARKS motifs in the H3 tail (H3K9me and H3K27me) (Figure 1.8A; boxed in
red).
While the Polycomb “readers” and “writers” are fairly well understood
in Drosophila (Figure 1.8A), in higher organisms, the specificity of effector
interaction, such as chromodomain recognition becomes murky and less
understood. In particular, the Chromobox (Cbx) chromodomain-containing
proteins underwent a massive expansion in mammals, with a total of five
Cbx paralogs compared to one protein in Drosophila, known as Pc. It has
been shown that not all chromodomains (CDs) within the Cbx family of
highly conserved chromodomains within the Polycomb family display affinity
towards both histone H3 trimethylated at K9 and H3K27 (Bernstein, Duncan
et al. 2006). Some display preferential affinity towards histone H3K9me3
and some towards H3K27me3. While H3K9 and H3K27 are identical in
surrounding sequence profile, the distinct functions of these marks is
intriguing. It has been suggested that residues immediately preceding the
ARK(S/T) motif impact on the specificity of chromodomain interactions
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(Fischle, Wang et al. 2003). Amino acids proximal to the substrates, or
motifs on the effectors outside of key conserved domains could be
contributing to the specificity of these interactions (Fischle, Wang et al.
2003). Thus, in order to detect additional unannotated domains, and motifs
in these complex proteins, a bioinformatics sequence based method and
phylogenetics approach is useful to gain insight about these set of highly
conserved, yet functionally divergent proteins. In Chapter 4, I discuss the
domain finding method I performed to detect additional unannotated
domains within the PcG family of proteins in multiple organisms in order to
infer gene expansion and diversification. In the remainder of this chapter, I
briefly introduce PcG complexes and their core functions.
PcG complexes and their evolutionary history
The PcG proteins are structurally and functionally diverse and form large
multimeric complexes of two general types: Polycomb repressive complex 1
(PRC1) and PRC2 (Ringrose and Paro 2004) (Figure 1.8B). These
complexes post-translationally modify histone tails and are believed to
cooperate in transcriptional repression of target genes by altering local,
higher-order chromatin structure (Francis, Kingston et al. 2004; Sparmann
and van Lohuizen 2006).
Polycomb group complexes, which are known to regulate homeotic
genes, have now been found to control hundreds of other genes in mammals
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and insects. Polycomb complexes function as global enforcers of
epigenetically repressed states, balanced by an antagonistic state that is
mediated by Trithorax. These epigenetic states must be reprogrammed
when cells become committed to differentiation. PcG proteins were
originally identified in Drosophila melanogaster as factors necessary to
maintain cell-fate decisions throughout embryogenesis by repressing Hox
genes in a body-segment-specific manner (Kennison 1995). Now recognized
as a large family of chromatin-associated proteins conserved from plants to
humans, the PcG is involved in many cellular memory processes including
body patterning X inactivation in female mammals (Heard 2004) and
vernalization in plants (Sung and Amasino 2004).
Core PRC1 is composed of Polycomb (Pc), dRing, Posterior sex combs
(Psc) and Polyhomeotic (Ph) (Figure 1.8B) (Ringrose and Paro 2004).
Already annotated, Pc has an N-terminal chromodomain (CD) and a Cterminal Pc box CDs, which are found in many chromatin-associated proteins
and are well-characterized methyllysine-binding modules (Eissenberg 2001).
Specifically, the CD of Drosophila Pc binds most strongly to H3K27me3, the
modification generated by PRC2 (Fischle, Wang et al. 2003). The Pc box is a
15-amino acid motif necessary for transcriptional repression of target
genes and for interaction with dRing, the catalytically active subunit of PRC1
(Muller 1995). dRing, named for its RING-type zinc finger (Figure 1.8B), is
an E3 ubiquitin ligase that monoubiquitylates histone H2A at lysine 119
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(H2AK119ub) (Wang, Wang et al. 2004). This modification, along with
H3K27me3, is important for PcG-mediated gene repression (de Napoles,
Mermoud et al. 2004; Wang, Wang et al. 2004). The precise function of Ph
in PRC1 complexes remains to be characterized, but it has been speculated
that Ph might influence the spreading of PcG complexes (Kim, Gingery et al.
2002). Additional new plant studies display significant evidence of sequence
similarity between the C-terminal region of the PRC1 Ring finger proteins
and the ubiquitin (Ubq)-like family of proteins, thus defining a new Ubq-like
domain, the RAWUL domain. Analysis of the conserved domain architecture
among PRC1 Ring finger proteins revealed the existence of long sought PRC1
protein orthologs in these organisms, suggesting the functional conservation
of PRC1 throughout higher eukaryotes (Sanchez-Pulido, Devos et al. 2008).
Additionally, these proteins have multiple domains and not all have been
annotated in the protein databases. Thus, being able to detect these
domains through bioinformatic methods can potentially help us identify the
distinct roles of PcG proteins and their cooperative mechanisms. The Cavalli
lab bioinformatically performed a phylogenetics analysis of PcG proteins on a
broad spectrum of eukaryotes, and Hox gene clusters were mapped onto the
species. Phenotypes of PcG mutants and the strong binding of PRC1 to Hox
gene clusters in flies and vertebrates suggested that these clusters are
important PRC1 targets. Thus, one hypothesis might be that PRC1 genes
can be lost as a consequence of the disintegration of the Hox gene cluster,
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which occurred repeatedly during evolution (Schuettengruber, Chourrout et
al. 2007). In Chapter 4, I will describe my aim to address the evolutionary
expansion and diversification of the PcG family of proteins.
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Figure 1.8: Polycomb schematic representations.
A. Schematic representation of the H3 N-terminal tail. Shown are Drosophila proteins with
rectangles representing the “writer” enzymes, and half moons representing effector “reader”
molecules. The “ARKS” motif is boxed in red. Note although the ARKS sequence motif is
identical in the two H3 positions (9 and 27), a different set of readers and writers exist for
these two lysines. Note the gene “ON” and “OFF” mechanisms associated with the specific
methylation marks.
B. Schematic representation of known core members of PRC1 and PRC2 complexes.
Drosophila proteins are shown as colored ovals; mouse homologs of these proteins are
listed adjacently. Gray boxes denote the mammalian homologs discussed in detail
throughout the text.
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Chapter 2: Computational Prediction of Acetylation Substrates
Summary
Acetylation is a well-studied post-translational modification that has been
associated with a broad spectrum of biological processes, notably gene
regulation. Many studies have contributed to knowledge of the enzymology
underlying acetylation, including efforts to understand the molecular
mechanism of substrate recognition by several acetyltransferases, but
traditional experiments to determine intrinsic features of substrate site
specificity have proven challenging. In this project, in collaboration with Dr.
Eran Segal at The Weizmann Institute of Science (Rehovot, Israel), I
performed a clustering analysis of protein sequences to predict protein
acetylation based on the sequence characteristics of acetylated lysines
within histones. I utilized the local amino acid sequence composition that
represents potential acetylation sites by implementing a clustering analysis
of histone and nonhistone sequences. I demonstrated that this sequence
composition has predictive power on two independent experimental datasets
of acetylation marks. Finally, I detected acetylation for selected putative
substrates using mass spectrometry as described Chapter 3, and report
several novel nonhistone acetylated substrates in budding yeast. My
approach, combined with more traditional experimental methods, may be
useful for identifying acetylated substrates proteome-wide. In this chapter,
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I adapted text from the publication (Basu, Rose et al. 2009).
Results
Training, key assumptions, and method
I used histones as a training set because of the wealth of information known
about their PTM patterns and well-developed purification and analytical
detection methods and focused on the major human core histones bearing a
total of 56 lysines (H2A: 13, H2B: 19, H3: 13, H4: 11) (Figure 2.1A). To
date, MS and antibody data suggest that there are 23 “validated” acetylated
lysines and 33 lysines that have “not yet been observed as acetylated” in
human histones based on literature (see Appendix for table). I sought to
uncover additional acetylation sites within the “not observed” class of lysines
in a systematic, rigorous manner via my computational method. I selected
parameters that could influence my ability to predict acetylation sites on
histones by making a series of assumptions. First, I focused my attention on
short stretches of amino acids N- and C-terminal of all 56 lysines. Since
structural studies of published KAT domains coupled with peptide substrates
typically do not exceed 14-20 amino acids in length (Marmorstein 2001), a
sliding window of a maximum number of 12 residues flanking each lysine
was chosen (Figure 2.1B). Residues most proximal to the lysine were
given the highest weight (Figure 2.1B), assuming that these residues are
most important for enzyme recognition, as several studies have shown
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(Marmorstein 2001; Marmorstein and Roth 2001). The weight function and
additional details on how I weighted residues is described in the Appendix.
Second, I varied standard Blast sequence alignment parameters including
gap penalty, extension, insertion, and deletion scores (Figure 2.1C). For
lysines in the extreme N- and C-terminal region, such as H3K4 or H2AK129,
I normalized the raw alignment score based on the length of the sequence.
Additionally, both orientations of the protein sequence (N-terminal to Cterminal or vice versa) were weighted equally. For sequences with lysines
located in close proximity to each other, such as H3K36 and H3K37, I
restricted the alignment matrix so that these sequences did not receive an
alignment score. This restriction prevented my training set to be
overrepresented with sequences from overlapping fragments of the same
protein. Finally, I compensated for structural accessibility by penalizing
buried lysines, while improving the score of accessible lysines (Luger, Mader
et al. 1997). This, however, did not influence my ability to predict
acetylation sites on histones, and therefore was not included in my further
computations.
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Figure 2.1: Schematic of computational approach
A. Human core histone proteins (H2A: orange, H2B: red, H3: blue, H4: green) containing
56 lysines (black) were taken as input data for computational training.
B. A sliding window of amino acids (black bars) flanking the input lysine (at position 0) is
used to train the model. Not all window lengths are shown. Weights (calculated as inversely
proportional to distance [d]) are applied to amino acids based on the distance from the
input lysine to the amino acid in positions -12 to +12.
C. BLAST sequence alignments are performed between all 56 lysines and surrounding
sequences and the highest scoring alignment is selected to begin the clustering analysis.
Shown are sequences H4K5 and H3K36 (boxed in red) spanning positions -6 to +6 and their
highest scoring match (denoted by a checkmark). Note that H4K5 and H2AK5 do not have
six residues flanking the lysine N-terminally; scores are normalized based on length in these
cases.
D. Lysines clustered together based on sequence alignment scores creating a fully predictive
hierarchical tree (four sequences are shown here; all 56 sequences are shown in Fig. 2.2).
E. Sequences are color coded according to published data on their modification state. Red:
“validated” evidence of the lysine being acetylated, green: this lysine was “not observed” as
being acetylated in literature.
F. After establishing PredMod, predictions were made on lysines in human core histones.
The algorithm was then validated using a set of human acetylated proteins reported in
literature, substrates detected using a pan-acetyl IP approach, and a yeast proteome-wide
dataset. Finally, predictions were made on yeast nonhistone sites and validated in vivo.
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I performed a hierarchical clustering of core histone lysines based on
the sequences surrounding each of these given lysines. All 56 histone core
sequences were aligned to each other creating a matrix of pairwise
alignment scores; generating a hierarchical tree of histone sequences
(Figure 2.1D). I next classified each lysine into one of two categories
based on its acetylation status reported in literature: “validated” (23
lysines), or “not observed” (33 lysines) (see Appendix). Finally, I visually
categorized each of the 56 lysines by color-coding my tree based on the
acetylation status of each lysine (Figure 2.1E).
To assess how robust the clustering was and how well it could actually
predict lysine acetylation (Figure 2.1F1), I took all 56 lysines and
performed a Leave One out cross-Validation (LOV) (Cooper, Aliferis et al.
1997) by iteratively excluding one lysine from my training set. Next, I
reconstructed the hierarchical tree with the remaining 55 lysines, and
incorporated the excluded single lysine observation as test data. For each
set and combination of predefined parameters (stated above) and in a single
run, I performed a LOV analysis to examine the predictive power on all 56
lysines to discover which set of parameters best optimized classification
power. If two lysines were in overlapping fragments of the same protein, I
excluded both of these lysines from my training set when either lysine was a
test case. I took each test lysine (56) and traversed through my training
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tree to find which subgroup of sequences my target sequence formed the
tightest cluster with.
A Receiving Operating Curve (ROC) analysis was performed on my test
dataset (Figure 2.2), where the statistics measure used was the Area Under
Curve (AUC). An AUC of 1 represents a perfect prediction and an AUC of 0.5
random predictions. Each point on a single curve of the ROC plot was
calculated by measuring the false positive versus true positive rate of the
performance on all 56 lysines for a given parameter(s) under a cutoff
alignment score. If the “test lysine” clustered within a group of “validated”
acetylated lysines (Figure 2.3; red color) above the cutoff score, the lysine
was predicted to be acetylated. Conversely, if the test lysine clustered
within a group of “not observed” lysines (Figure 2.3; green color) above the
alignment score, the lysine was predicted as not acetylated. The default
status of the lysine when it did not fall into the above criteria was “not
acetylated.” The best ROC plot achieved an AUC of 0.80, and the
parameters in this case included six weighted residues to both the left and
right of the tested lysine (Figure 2.2). A threshold for prediction was also
determined based on this plot. To test the significance of this score, I
applied the above procedure to 1000 random permutations of the labels of
the observed and not observed lysines. The median AUC in these
permutations was 0.64 and the maximum score was 0.79, and thus, my AUC
was statistically significant (p<0.001).
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Computational prediction of novel human histone acetylation marks
and in vivo validation by mass spectrometry
After hierarchical clustering of all the lysine-embedded histone
sequences, I next sought to predict novel acetylation sites in the human core
histones. As the tree illustrates in Fig. 2.3, “not observed” lysines that
clustered tightly with “validated” acetylated lysines (black arrows) were
potential acetylation targets because of their similar sequence constitution.
Based on the threshold, as determined by the ROC plot, I selected these as
candidate sites. The method described above predicted seven novel
acetylation sites in the human core histones; four in H2A (K9, K13, K125,
K127), one in H2B (K116), one in H4 (K44), and one in H3 (K37) (Figure
2.3; black arrows, for enlarged view of tree, please see Appendix). This
large number of predictive sites was unexpected, since histones have been
intensely investigated for PTMs in recent years. I describe all details of my
in vivo validation in Chapter 3. In summary, I correctly predicted four of
these seven acetyl-lysine sites suggesting that the algorithm is capable to
identify acetylation sites in human histone proteins. I also selected a small
number of lysines that I predicted with high confidence as “not acetylated”.
These lysines were H3K64 and H3K115, and preliminary results display that
these lysines to my knowledge have not been observed as acetylated
(personal communication, K. Rose).
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Figure 2.2: Computational prediction of human histone acetylation sites
ROC curve using LOV on the 56 human histone lysines for selected parameters. True
positive rate (y axis) versus false positive rate (x axis). Win=(x,y) denotes the length of
residues spanning the lysine; x represents the number of residues N-terminal to the lysine
and y represents the number of residues C-terminal to the lysine. Win=4,3, AUC=0.74;
Win=6,6, AUC=0.79; Win=8,8, AUC=0.53. Diagonal line represents a random prediction.
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Figure 2.3: Predictive hierarchical tree of all 56 lysines in human core histones
Predictive tree of all 56 lysines from human core histone sequences using hierarchical
clustering. Histone lysines (in red or green) are color coded according to published data on
their modification state as described in Fig. 2.1E. For each pair of sequences under a single
node, amino acids are colored in light purple (identical residues) or dark blue (in accordance
with the BLOSUM matrix). Underlined red lysines represent the residue that was used for
training the algorithm. Dashed red vertical line represents the selected threshold used to
make predictions. Grey boxes represent lysines that cluster together. Black arrows
represent those lysines predicted as acetylated. For an enlarged view of tree, please see
Appendix. An “R” next to the lysine indicates that a C- to N-terminal arrangement was
used in the alignment.
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Figure 2.3
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Nonhistone sequence based dataset prediction and validation
Since my computational analysis revealed a high level of sequence
homogeneity among acetylated lysines within histone proteins, leading to
the successful prediction of novel modified residues, I next wondered if my
approach might also enable us to predict nonhistone acetylation sites as well
(Figure 2.1F2). In my first approach, I included a dataset that contained
both nuclear and cytosolic proteins from HeLa cells, which were
immunoprecipitated with a pan-acetyl antibody (Figure 2.4A) and identified
by MS (Kim, Sprung et al. 2006) (see Appendix for full list). The
precipitate contained peptides with a total of 1413 lysines, and 51 previously
validated acetylation sites. With PredMod, I was able to predict 34 (67%) of
these sites correctly (Figure 2.4C) when they were surrounded by six
residues to the left and right (AUC= 0.75, sensitivity (Sn)=0.60, specificity
(Sp)=0.91) (Figure 2.4C; orange curve). In total, 6% (85) of the total
number of lysines were predicted that were not validated as acetylated (Fp
< 6%). Fp is a maximum false positive rate since a true negative count
cannot be accurately determined because many of these lysines could
potentially be acetylated, but not detected under the experimental
procedures used.
In my second dataset, I compiled a list of 32 proteins containing 1378
lysines with 73 of these reported in literature to be acetylated in vivo and/or
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in vitro (Figure 2.4B, see Appendix). With PredMod, I predicted 39 out of
73 (53%) lysine marks accurately with Fp < 6.5% (AUC= 0.74, Sn=0.58,
Sp=0.91) when these were surrounded by six residues to the left and right
(Figure 2.4D; orange).
Both test datasets exhibited a decrease in performance when larger
numbers of residues N- and C-terminal to the target lysine were used (blue
line), suggesting that KATs may recognize a smaller and defined set of
residues. Overall, my results from both approaches revealed that my
selected parameters for histones were also valid for the prediction of
acetylated nonhistone substrates using a ROC analysis approach.
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Figure 2.4: Prediction performance on test set of human acetylated substrates.
A. Pan-acetyl immunoprecipitated substrates. Black line represents the full-length protein.
Red filled circles indicate lysines that are predicted and correctly validated in their positions
relative to the full-length of the protein. Red empty circles indicate lysines predicted, but
not validated under the experimental conditions tested in their positions relative to the fulllength of the protein.
B. Literature validated human acetylated proteins. Symbols are the same as in A.
C. ROC curve for human pan-acetyl IP substrate test set. Y axis represents the true positive
rate and X axis the false positive rate. Win=(x,y) denotes the length of residues spanning
the lysine; x: number of residues N-terminal to the lysine; y: number of residues C-terminal
to the lysine. Diagonal line represents a random prediction.
D. ROC curve for human literature-validated test set. Symbols are the same as in C.
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Figure 2.4
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Analysis of acetylation motifs
I next sought to understand which amino acids play a critical role in
acetylation site selection and asked whether there were preferences for
certain amino acids near the target acetylated lysines in my datasets.
Notably, when I examined the surrounding residues (six residues to the left
and right) of a “validated” acetylated lysine versus a “not observed” one in
human histone and nonhistone proteins I discovered an enrichment for small
residues (G/A in pink), lysines (K in green), and phosphorylatable residues
(S/T in blue) (Figure 2.5). To test whether the observed enrichment of G,
K, and S was statistically significant, I determined the frequency of these
residues flanking a lysine in the entire human proteome. I noticed that on
average, these residues were of significantly higher frequency in my
datasets than in the human proteome. I employed the hypergeometric test
to measure the statistical relevance of this observation. For a table with all
the p-values of these statistical observations (see Appendix for full list of
values).
My results display that the most significant p-values were found in the
category of small residues (p<0.01 in multiple flanking positions, Figure
2.5, tick marks), suggesting that small amino acids, perhaps due to their
sterically undemanding side chains, could accommodate the flexibility of the
substrate thus allowing protein docking and catalysis. This observation was
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in agreement with a previous study (Schwartz, Chou et al. 2009), which
revealed that glycine preceding lysine was common among acetylated
lysines. In conclusion, I was able to identify a significant enrichment of
mainly small amino acids and lysines surrounding “validated” acetylated
lysines in comparison to “not observed” ones, suggesting that KAT enzymes
have a general need for specific residues for recognition and/or activity.
These observations are in agreement with studies of several KATs with test
substrates (Marmorstein 2001).
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Figure 2.5: Frequency distribution of amino acids surrounding lysines in human
histone and nonhistone proteins.
A. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in validated
acetylated lysines in histone proteins (23 lysines). Residues in green: basic, red:
hydrophobic, pink: small, blue: S/T, black: all other residues. Underlined red K: lysine that
has been validated experimentally as acetylated, and an underlined green K: lysine that has
not been experimentally observed as acetylated. “X” denotes that no amino was present in
that position.
B. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in validated
acetylated lysines within proteins in literature (73 lysines). Colors represented same as in A.
C. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in validated
lysines in the pan-acetyl IP substrates (51 lysines). Colors represented same as in A.
D. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in “not observed
as acetylated” lysines in histones (33 lysines). Colors represented same as in A.
E. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) not observed as
acetylated lysines in proteins as reported in literature and not observed as acetylated
lysines in pan-acetyl IP substrates (3493 lysines). Colors represented same as in A.
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Figure 2.5
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S.cerevisiae proteome-wide prediction
The previous predictions were performed with human proteins, and I
therefore wondered whether my algorithm would also be able to predict
acetylation sites in proteins from other organisms (Figure 2.1F3). Since
histone acetylation has been studied extensively in budding yeast, I
assessed the performance of my model on a proteome-wide dataset that
included acetylated peptides in S. cerevisiae (Craig, Cortens et al. 2006)
(see Appendix for details). In addition, I experimentally validated my
predicted acetylation sites in candidate yeast nonhistone proteins in vivo.
In my first approach, I examined an in vitro proteome-wide dataset of
acetylated peptides of S. cerevisiae that contains 356 peptides including also
acetylated histone peptides. This dataset allowed me to approximate the
number of yeast acetylation events on a global level (0.6%; 356 acetylated
peptides out of approx. 50,000 total non-redundant peptides), and the
substrates themselves allowed me to further validate my prediction
algorithm. I filtered these protein-derived peptides according to their
cellular compartment (nuclear vs. cytoplasmic) (Huh, Falvo et al. 2003), and
correctly predicted 48% of acetylation events on nuclear proteins (79 lysines
total, AUC= 0.71, Sn=0.63, Sp=0.92, Fp < 4%), and 31% on the
cytoplasmic proteins (248 lysines total, AUC= 0.70, Sn=0.61, Sp=0.90, Fp <
5%) (Figure 2.6A, B). I also noted that nuclear yeast proteins showed a
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similar enrichment for small residues surrounding the target lysine, as found
in the human substrates (Figure 2.7; tick marks). Given the mass
resolution of many of the spectra used to create the yeast library, it was not
possible to distinguish a priori between acetyl-lysine and trimethyl-lysine on
the basis of the tandem spectra alone. Thus my yeast proteome-wide
dataset could potentially contain tri-methylated peptides. Since there are
few reported trimethyl marks across the yeast proteome, and my dataset
does not contain the previously validated yeast histone trimethylated sites
H3K36, H3K79, and H3K4 (Garcia, Hake et al. 2007), I believe that the
number of trimethyl sites in the dataset could be small. In accordance, my
dataset contains the following peptides: H3K9 (Suka, Suka et al. 2001),
H3K14 (Suka, Suka et al. 2001), H3K18 (Suka, Suka et al. 2001), H3K27
(Suka, Suka et al. 2001), H3K56 (Xu, Zhang et al. 2005), H2BK11 (Suka,
Suka et al. 2001), H2BK16 (Suka, Suka et al. 2001), H4K5 (Suka, Suka et
al. 2001), H4K8 (Suka, Suka et al. 2001), H4K12 (Suka, Suka et al. 2001),
and H4K16 (Suka, Suka et al. 2001); all yeast acetyl marks validated in
literature. Of note, my current prediction accuracy could be limited by an
underrepresentation of acetyl-lysines, and it would be interesting to see how
my accuracy improves with datasets obtained using more sensitive MS
techniques.
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Figure 2.6: Performance on Yeast Proteome-wide Dataset
A. Pie chart reflecting correctly predicted lysines on nuclear versus cytosolic peptides in S.
cerevisiae. Peptides were generated from Global Proteome Machine database. Nuclear
peptides (108 peptides) and cytosolic peptides (248 peptides) shown.
B. Performance accuracy (#correctly predicted as acetylated/total number of positives) and
false positive rate on nuclear peptides versus cytosolic peptides. Individual training sets
(histones, nuclear, and cytosolic proteins) used to perform accuracy. The first number in
table cell reflects accuracy, and second number after the | reflects the percentage of lysines
predicted as acetylated in the test dataset (Fp).
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Figure 2.7: Frequency distribution of amino acids surrounding yeast lysines
A. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in validated
acetylated lysines in yeast nuclear histone and nonhistone proteins (108 lysines). Residues
in green: basic, red: hydrophobic, pink: small, blue: S/T, black: all other residues.
Underlined red K: lysine that has been validated experimentally as acetylated, and an
underlined green K: lysine that has not been experimentally observed as acetylated. Tick
marks represent residues described in text.
B. Frequency of amino acids in validated acetylated lysines in yeast nuclear proteins
excluding histones (79 lysines). Colors are as in A.
C. Frequency of amino acids in validated acetylated lysines in yeast cytosolic proteins (248
lysines). Colors are as in A.
D. Frequency of amino acids in not observed as acetylated lysines in yeast nuclear and
cytosolic nonhistones (13814 lysines). Colors are as in A.
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In my second approach, I validated my predictions on three yeast
candidate proteins that had previously not been published to contain
acetylated sites (Spt6 (Clark-Adams and Winston 1987), Sir3 (Gasser and
Cockell 2001), and Eaf7 (Krogan, Baetz et al. 2004). With PredMod, I
predicted 15 sites to be acetylated out of 416 total lysines in my three
candidate proteins combined. Four of these, within my top six ranked
predicted sites were validated as acetylated by MS and therefore predicted
correctly (more detail in Chapter 3). Since the total number of acetylated
lysines in the yeast proteome is approximately 0.6% my in vivo hit rate of
approximately 25% is of reasonable accuracy.
Finally, in order to allow users to view predictions of their favorite
protein, I developed a software tool, PredMod, which allows a user to enter a
protein of choice and view all lysines, with their respective confidence scores
with which they are predicted (Figure 2.8)(described further in Appendix).
Users can also view lysine predictions of substrates that were contained in
both independent validation sets as well as histone proteins including
variants in multiple organisms. In the future, PredMod will potentially be
powerful for identifying bonafide acetylation sites in nonhistone proteins, and
further display the strength of using histone sequences as a useful guide for
nonhistone acetylation prediction.

69

Figure 2.8: PredMod, an acetylation prediction tool
PredMod, an acetylation prediction tool was developed for a user to enter a protein of choice
and obtain a list of predicted acetyl lysines with a confidence score for the lysine.

70

Chapter 2 Discussion
My results suggest that the “sequence environment” in both histone and
nonhistone proteins contributes to the likelihood of acetylation. Consistent
across both human and yeast acetyl datasets, I noticed an enrichment of
small residues, particularly glycine, and charged amino acids flanking
validated acetylated lysines (Figure 2.5, Figure 2.7; tick marks). It is
possible that I am perhaps achieving a higher accuracy for nuclear proteins,
since the KAT substrates (histones) I used for training PredMod, mostly
reside in the nucleus. My results also suggest that nuclear versus
cytoplasmic KATs in yeast could possess unique substrate recognition
profiles as illustrated by the differences in preferred flanking residues Cterminal to the lysine (Figure 2.7). In order to address whether histones
were the best training set for nonhistone prediction, I retrained my
algorithm with nonhistone lysines exclusively. I compiled lysines in both the
literature scanned and pan-acetyl datasets together, and observed whether I
would perform better using the nonhistone set for training purposes. I used
five-fold cross validation on the datasets, thereby training on 4/5 of the
dataset, and retesting on 1/5 of the dataset. I obtained an accuracy of 65%
when training on histones, and 60% when training on nonhistones. When I
trained on nonhistones to predict histones sites also using cross validation, I
obtained 54%. Interestingly, I achieved a higher accuracy when training on
histone versus nonhistone proteins. This could be due to the fact that in my
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nonhistone dataset, I have a heterogeneous distribution of enzymes, due to
the fact that this set contains both nuclear and cytosolic proteins. A
compartmentalization between nuclear and cytoplasmic proteins could help
achieve better results.
In my computational analysis, as shown in Figure 2.5, I observed that
15 out of the 51 pan-acetyl lysine substrates contained a histidine adjacent
to the lysine (C-terminal) (Figure 2.5C). It is possible that this pan-acetyl
antibody has a specific preference for histidine immediately adjacent to the
acetylated lysine (Figure 2.5C). Whether the observed enrichment of
histidines is due to a bias of the antibody or whether it could be part of a
KAT recognition motif needs to be further explored. In contrast to the
enrichment of small residues flanking validated acetylated lysines, I did not
observe an enrichment of small amino acids surrounding “not observed”
lysines in human histones and nonhistones therefore strengthen my
confidence in the pronounced signal among acetylated lysines (Figure
2.5D,E).
An area that was unexplored that would be interesting to delve into is
whether structural information could add to the predictive power of the
algorithm. Thus, if a given lysine is located within a loop, beta-strand or
alpha-helix, I can add this information onto the algorithm, where a lysine
within the loop region would be more exposed than a lysine within a betastrand. Current structural prediction programs such as Psi-Pred and other
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prediction programs can aid in predicting these regions, and as a result the
misclassified data may become true positives.
The prediction program, PredMod that I developed is a promising step
in detecting additional novel acetylation sites. A study that has been
recently published involves a quantitative proteomics approach to detect
acetylation substrates (Choudhary, Kumar et al. 2009). One of the major
findings of the study is that lysine characteristics of sequences in
mitochondria, nuclear, and the cytoplasm are divergent from each other
(Choudhary, Kumar et al. 2009). They observed the following results: all
acetylated substrates have high frequency of tyrosines in the +1 position. I
suspect that this could be due to the bias of pan-acetyl antibody that was
used in their study, which resembles the high frequency of histidine in the
+1 position on my pan-acetyl antibody dataset. In agreement with my
analysis, they find an enrichment for glycine in the -1 position within their
nuclear acetyl sites, unlike the cytosolic sites that do not show this type of
preference. They also discover a high frequency of lysines surrounding
acetylated lysines, which is also in agreement with my studies. Conclusions
such as this from these types of large scale studies makes me curious as to
whether incorporating other modifications that are potentially on the same
peptide could be included into the algorithm. Since it is known that there is
cross-regulation occurring between modifications on histone tails, and even
nonhistones, a parameter that I could add to the algorithm would be to
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include other modifications that are present within the flanking residues of a
target lysine. Information on additional peptide modifications from the
Global Proteome Machine Database (GPMDB) would be useful to incorporate
on a proteome-wide scale. In the early stages when I was developing the
algorithm, I utilized this same approach on histone modifications in order to
derive whether multiple modifications within the same region of the histone
would influence my histone predictions overall. For example, if the target
lysine was H3K9ac, instead of representing the +1 residue relative to H3K9
as H3S10, this residue was represented as phosphorylated H3S10. Using this
method, I achieved an accuracy of 70%, which is lower than my current
prediction accuracy. One possibility of why I may have been achieving a
lower prediction accuracy could be that I was overspecifying the training set,
resulting in some of the true positives being missed. More complete
quantitative data such as the abundance levels of additional PTMs, could be
crucial for my algorithm performance.
Overall, my results suggest that KATs target specific sequence
patterns, and that the predictive knowledge about histone acetylation
provides a platform for studying both histone and nonhistone lysine
acetylation. My model and results represent a step towards gaining a
framework for predicting lysine acetylation sites in both human and yeast
proteomes. It will be of interest in future studies to see whether my
algorithm is capable of predicting lysine acetylation sites in many other
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organisms. As more substrates in the acetyl-proteome are discovered (Yang
and Seto 2008), it is likely that the predictive power of my approach will be
strengthened, leading to more accurate confidence in the predicted site.
Though my training dataset is 10-100 times in magnitude lower than other
PTM datasets including acetylation (9, 21, 22), my approximate sensitivity
measure of 60% is comparable and often higher than other prediction
algorithms that achieve as low as 16-18% sensitivity (Blom, SicheritzPonten et al. 2004; Saunders, Brinkworth et al. 2008; Schwartz, Chou et al.
2009). It would be interesting to see whether similar approaches could be
applied to the prediction of other widespread histone modifications such as
lysine methylation.
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Chapter 3: Experimental validation of predicted acetylation targets
Summary
In this chapter, I describe the validation of my computationally predicted
targets through wet-bench experiments that I performed in the Allis
laboratory. In collaboration with the Don Hunt laboratory at the University
of Virginia (Charlottesville, VA), and the Yingming Zhao laboratory at the
University of Texas Southwestern Medical Center (Dallas, TX), I describe
several novel acetylation marks in human histones and yeast nonhistone
proteins that were correctly validated through my computationally oriented
algorithm (as described in Chapter 2) via mass spectrometry. These marks
further validate my computational algorithm and illustrate that primary
sequence context of histone and nonhistone lysines are a driving factor in
acetylation target and recognition. In addition, in order to determine
acetyltransferase rules and pinpoint residues that could be critical for
enzymatic recognition, I present data on yeast mutagenesis experiments
that I performed in histone H3 in collaboration with the Ben Garcia
laboratory at Princeton University (Princeton, NJ). These results have led to
testable models and hypotheses that may be further explored.
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Results
In vivo validation by mass spectrometry
In Chapter 2, I described the computational method that I used in
order to predict acetylation marks in histone and nonhistone proteins. As
described in Chapter 2, I predicted seven novel acetylation sites in the
human core histones; four in H2A (K9, K13, K125, K127), one in H2B
(K116), one in H4 (K44), and one in H3 (K37) (Figure 2.3). This large
number of predicted sites was unexpected, since histones have been
intensely investigated for PTMs in recent years. To test whether these
predicted lysines are acetylated in vivo, the Don Hunt lab employed an MSbased approach to examine histone peptides from human cell lines (Hela and
HL60) that were asynchronously growing and treated without any HDAC
inhibitors. HDAC inhibitors were excluded so that I could capture the nonhyper levels of acetylation in the asynchronously growing cells.

All peptides

containing the predicted lysines were identified, and importantly four of the
seven predicted acetyl-lysines were experimentally validated: H2AK9,
H2AK13, H2AK125, H2AK127 (Figure 3.1). In collaboration with the Ben
Garcia lab, I also looked at histone acetylation marks under sodium butyrate
treatment (an HDAC inhibitor), to assess whether this condition would result
in an altogether different set of acetylation marks which could potentially
alter my training set composition or prediction accuracy on the algorithm.
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Under sodium-butyrate treatment, Hela cells displayed H3K37 and H2BK116
acetylation, two of my predicted acetylation sites, (personal communication,
Ben Garcia), however since these marks were only observed under these
special conditions, I did not count them as bonafide “validated” sites.
Additional acetyl marks observed under sodium butyrate treatment were:
K95, K119 in H2A; K34, K46, K108, K116 in H2B; K77, K79, K91 in H4, and
K37 in H3. Incorporating these sites into my training set of “validated”
lysines did not alter the prediction performance of my algorithm significantly.
In summary, I correctly predicted four of these seven acetyl-lysine
sites suggesting that the algorithm is capable to identify acetylation sites in
human histone proteins.
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Figure 3.1: Validation on histone predicted lysines
Human H2A and H2B, H3, and H4 sequences are shown. Literature-validated acetylated
lysines are red, and lysines which have not been observed as acetylated are green. Lysines
in blue under filled green circle were not predicted as acetylated, but validated under
experimental conditions tested using LC/MS/MS. Lysines in blue under filled red circle were
predicted as acetylated, and validated under experimental conditions tested using
LC/MS/MS. Lysines in green under open red circle were predicted as acetylated, but have
not yet been validated under experimental conditions tested.
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Yeast in vivo validation
The previous predictions were made on human histone and nonhistone
datasets, and I therefore wondered whether my algorithm would also be
able to predict acetylation sites in proteins from other organisms. Since
histone acetylation has been studied extensively in budding yeast, I
assessed the performance of my model on a proteome-wide dataset that
included acetylated peptides in S. cerevisiae (Craig, Cortens et al. 2006)
(Chapter 2). In addition, I experimentally validated predicted acetylation
sites in candidate yeast nonhistone proteins in vivo.
An outline of my overall approach and method is as follows: I) I ran
the algorithm against the 30 chromatin-associated proteins (of interest to
the Allis Lab) in the S. cerevisiae proteome by taking a sequence stretch of
six residues N- and C-terminal to the target lysine because of the promising
human ROC results. I used the nonhistone lysine traversal method described
in Chapter 2 and applied to the human histone-trained tree to find which
subgroup of sequences the nonhistone yeast sequence formed the tightest
cluster with. Based on the threshold score that was determined by the
human ROC analysis, I then selected candidate proteins that had the highest
scoring alignments with acetylated histone sequences. The highest ranked
predicted lysine acetylation sites were in the proteins Cac2 (component of
the chromatin assembly complex) (Enomoto and Berman 1998), Spt6 (a
transcriptional elongation factor and nucleosome disassembly factor) (Clark80

Adams and Winston 1987), Sir3 (a silencing factor that establishes a
transcriptionally silent chromatin state) (Gasser and Cockell 2001), and Eaf7
(an Esa1 associated factor) (Krogan, Baetz et al. 2004). Additionally, for
each of these proteins, I ranked in order of confidence lysines that would be
predicted as likely KAT targets. III) I then purified my candidate proteins by
performing a TAP purification (Figure 3.2A) and subsequently analyzed
these via mass spectrometry according to previously published rules (Chen,
Kwon et al. 2005).
In conclusion, I validated my predictions on three yeast candidate
proteins that had previously not been published to contain acetylated sites
(Spt6 (Clark-Adams and Winston 1987), Sir3 (Gasser and Cockell 2001),
and Eaf7 (Krogan, Baetz et al. 2004). I expressed and purified the TAPtagged candidate proteins in S. cerevisiae (Figure 3.2A) and subsequently
subjected them to LC/MS/MS. With PredMod, I predicted 15 sites to be
acetylated out of 416 total lysines in three candidate proteins combined.
Four of these, within the top six ranked predicted sites (Figure 3.2B,C,D),
were validated as acetylated by MS and therefore predicted correctly
(Figure 3.2B,C,D). Since the total number of acetylated lysines in the yeast
proteome is approximately 0.6% (discussed in Chapter 2), my in vivo hit
rate of approximately 25% is of reasonable accuracy.
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These results demonstrate the power of PredMod for identifying bona
fide acetylation sites in nonhistone proteins, and further display the strength
of using histone sequences as a useful guide for nonhistone acetylation
prediction.
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Figure 3.2: Novel predictions and in-vivo validations in S. cerevisiae
A. Coomassie-stained gel of TAP pulldown purification of yeast proteins Eaf7, Sir3, and
Spt6. Asterisks denote bands that were isolated and inspected for acetylation by MS.
B-D. Shown are regions of the sequence alignment where there is sequence identity or
similarity. A purple pair of amino acids represents identical residues and a blue pair of
amino acids represents residues that can be evolutionarily substitutable in accordance with
the BLOSUM matrix. A black bar below the alignment represents the length of nonhistone
protein. The numbers to the right represent the total number of amino acids (aa) and the
number of lysines (K) in the protein. Red filled circles depict lysines that were predicted
correctly on the yeast nonhistone substrate at the specific location relative to the full length
of the protein. Red empty circles represent lysines that were predicted, but not confirmed
by mass spectrometry under the conditions tested. Green filled circles represent lysines that
were not predicted, but validated experimentally by MS. A blue lysine with a red filled circle
on top represents those lysines that were correctly predicted. Boxed R represents the rank
of prediction among all predicted acetylated sites on the protein. B. Eaf7K343 (R=2)
sequence alignment with H4K5. C. Sir3K3 (R=4) sequence alignment with H3K56. Symbols
denoted as in B. D. Spt6K958 (R=1) and Spt6K319 (R=6) sequence alignments with H4K5
and H3K56, respectively. Symbols denoted as in B.
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Figure 3.2
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In vivo mutagenesis in budding yeast
My computational analysis in Chapter 2 led me to conduct experiments that
could help identify rules, or specific patterns that could potentially be
important for acetyltransferase recognition in order to address the question:
is immediate sequence context of lysine important in HAT recognition? From
my statistical and quantitative analysis methods, I came to the conclusion
that sequence context surrounding a target acetylated lysine can dictate KAT
substrate preferences. However, to fully test the effectiveness of my
approach, I wanted to perform specific wet-bench experiments to formalize
the rules necessary for enzyme recognition. Since my computational
analysis led to a frequency enrichment analysis of flanking residues
surrounding an acetylated lysine, I wanted to mutate these residues in vivo
to determine what effects these mutations might have on known PTMs. I
chose S. cerevisiae as the organism to perform site-directed mutagenesis in
because of its robust genetic manipulation techniques and easily available
reagents. Additionally, yeast H3 and H4 are highly conserved with human
H3 and H4 which were a part of the training set the algorithm was based on.
My first step was to examine the hierarchical tree in Chapter 2 (Figure 2.3),
in order to determine whether there were lysine embedded sequences under
the same cluster with similar flanking sequence profiles.
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Via the clustering analysis, I singled out a cluster containing two
sequences that were tightly paired (ranked as the tightest pair of sequences
in the tree). As shown in Fig 3.3A, these sequences were H3K14 and
H3K36. Close examination of the sequence alignment of these two
sequences reveals phosphorylatable residues in the -4 position, glycine in
the –1 position (small), a proline in the +2 position, and a basic residue in
the +3 position (Figure 3.3A). Also, H3K14 and H3K36 are both Gcn5mediated acetyl sites (Howe, Auston et al. 2001; Morris, Rao et al. 2007).
Furthermore, H3K36 is a bonafide trimethyl site, where the methylation of
this site occurs via the methyltransferase, Set2 (Strahl, Grant et al. 2002).
Additionally, both of these acetyl sites are associated with transcriptional
activation (Pokholok, Harbison et al. 2005), and H3K36me2 and H3K36me3
are associated with transcriptional elongation, and are needed to prevent
cryptic initiation (Kizer, Phatnani et al. 2005; Morris, Shibata et al. 2005).
The distinct functional roles of H3K36 acetylation and methylation made me
curious as to whether H3K14, a bonafide acetyl site, could also be
methylated if its sequence was mutated to resemble H3K36’s. I next
checked whether there was an existing literature of H3K14 methylation in
yeast. To my knowledge, there is no published literature of H3K14
methylation in organisms ranging from mammals to yeast to date (Garcia,
Hake et al. 2007).
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In order to address the question of whether H3K14 is methylated after
mutagenesis within the flanking residues, I mutagenized the flanking
residues of H3K14 to resemble H3K36. A key question that I could also
attempt to answer in parallel through these experiments was: how do H3K14
acetylation levels fluctuate as a result of specific mutations? The table below
(Table 3.1) displays the mutations that I chose to make, the rationale
behind why selecting these mutations would enable me to learn something
about acetylation based on my computationally derived frequency analysis
(Figures 2.5, 2.7), and a prediction of how acetylation levels would
increase or decrease upon making the selected mutations, which were
designed to resemble the flanking H3K36 sequence profile (Figure 3.3B):
Table 3.1: Mutations, Rationale, and Acetylation Prediction
Mutation

Rationale

Acetylation Prediction

G13->V

Valine is beta branched and more

Acetylation will be decreased, as

conformationally rigid as opposed to

glycines are enriched on the N-terminal

glycine with a flexible side chain.

side of an acetylated lysine.

Control. Since I mutated G13 to V

No change. Valines are present in the

on the left, a parallel mutation on

+1 position of acetylated substrates

A15->V

the right is a good control.
Lysine is a charged amino acid. Do

Acetylation could increase or decrease.

two adjacent charged residues have

There are lysines in the +1 positions of

an effect on lysine acetylation or

acetylated substrates, and in the “not

methylation?

observed as acetylated” substrates.

G13->V,

Double mutation, identical residues

Decrease in acetylation mainly caused

A15->K

surrounding H3K36

by the G13V mutation.

A15->K
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Figure 3.3: Mutagenized yeast histones
A. Blast sequence alignment between H3K14 and H3K36. Both sites are acetylated by Gcn5
and H3K36me can be mono, di, or tri-methylated. Colored residues either identical or
similar according to BLOSUM matrix(Eddy 2004).
B. Mutations that were made in H3 of budding yeast in vivo. Effect of methylation and
acetylation levels as a result of mutagenesis was the question I tried to answer in study.
C. Acid extracted histones (1 microgram) were electrophoresed in a 15% SDS-PAGE and
analyzed by Western blot. Shown is the marker (left) and the three strains that histones
were extracted from (right 3 lanes). These strains are WT, H3G13V, H3A15K, and H3A15V.
Untagged H3 (shown in second lane), and Myc-tagged H3 is shown with arrow (all other
lanes).
D. Western Blot using a general H3 antibody (Abcam) with same fractions as in C,
electrophoresed in a 15% SDS-PAGE gel.
E. Western Blot using H3K9ac (Abcam) and H3K23ac antibodies (Abcam) to display that
Myc-tag on the mutant strains did not affect acetylation levels of H3. Strains are H3A15K
(left) and H3G13V (right).
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Figure 3.3

89

I used a budding yeast plasmid shuffle strain (detail described in
Methods) to perform yeast mutagenesis by making the following H3 shuffle
plasmid mutations: H3A15K, H3G13V, and H3A15V. In the strain that I
wanted to make these mutations in, I shuffled out the WT plasmid and
inserted my mutant plasmid containing my desired mutation. To check
whether my strains had the correct mutations, I performed a plasmid
recovery followed by DNA sequencing. Once I confirmed that I had the
correct mutations in my yeast strains, I extracted yeast nuclei through
douncing and spheroplasting, and used an acid extraction procedure of
histone proteins (Figure 3.3C, D). Since the mutant strains were tagged
with a N-terminal Myc tag, I was concerned that the Myc-tagging could alter
the acetylation status of histone H3. Thus, I checked acetylation levels of
my WT versus mutant strains against the general H3, H3K9ac, and H3K23ac
antibodies (Figure 3.3D, E). In the mutants, acetylation was at a
comparable level to WT acetylation levels, suggesting that the Myc tag did
not grossly affect levels of acetylation. In collaboration with the Ben Garcia
laboratory at Princeton University, mass spectrometry analysis of WT and
mutant H3 was performed using LC/MS/MS, and the following results were
revealed: there was no methylation visible on H3K14 in either the WT or
any of the mutant strains. The double mutant strain (G13V, A15K)
displayed a lethality phenotype. While this could be interesting and worth
investigating, I chose not to follow up on it further at the moment. In all my
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mutant strains excluding my designated control (A15V), H3K14 acetylation
was decreased (Figure 3.4A); the most significant decrease was under the
alanine to lysine mutation in the +1 position as H3K14 decreased by fourfold (Figure 3.4A). Under this same mutation, H3K9ac increased by
approximately two fold. To my surprise, methylation levels of H3K36 were
also affected under the A15K mutation. I did not expect that distorting the
sequence immediately surrounding H3K14 would have such a pronounced
effect on H3K36 methylation levels, such that the unmodified form of H3K36
increased twenty fold, H3K36 monomethyl increased ten-fold (H3K36me1),
while H3K36 dimethyl (H3K36me2) and trimethyl (H3K36me3) levels
decreased by 1.5 fold (Figure 3.4 illustrates the exact values). Errors not
shown in figures as the experiments were performed only once. All mass
spectrometry figures can be found in the Appendix.
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Figure 3.4: PTMs as result of flanking residue mutations surrounding H3K14
A. Table displaying H3K9ac, H3K14ac,H3K36ac, H3K36me0, H3K36me1, H3K36me2, and
H3K36me3 levels as a result of making mutations H3A15K, H3G13V, and H3A15V. Numbers
represent percentage of the total that is modified. Yellow highlighted numbers represent
mutations where there were dramatic increases or decreases.
B. Bar graphs displaying values as denoted in (A) for both H3K14 and H3K36 peptides. Note
the fold percentage differences between H3K36me0, and H3K36me1.
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Figure 3.4
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Chapter 3 Discussion
Here I show that I can predict novel acetylation sites in proteins of interest
in both human and yeast cells. Furthermore, I have shown that there are
residues that may be critical for lysine acetyltransferase recognition and
demonstrated that there could be a “crosstalk” occurring between three
marks on the histone H3 tail H3K9, H3K14, and H3K36. Together my data
can lead to a predictive understanding of acetylation by examining the
sequence of the targets themselves.
Using a combined experimental/computational approach, I identified
several sites in human histone and nonhistone proteins that were correctly
predicted. There were, however, a class of lysines that were predicted by
my algorithm, yet have not yet been detected experimentally. Several
possibilities can be envisioned for this case: first, the MS approach has
limited detection and sensitivity capabilities and cannot recover peptides that
are acetylated at only low levels. Second, lysines could be modified only in
distinct environmental conditions, cell cycle stages, cell types, and are
therefore undetectable in the cell extracts I used. Here it should be noted
that additional novel histones acetylation sites were detected by MS/MS
when Hela cells were pretreated with HDAC inhibitors (personal
communication, B. Garcia), and I retrained the algorithm with this data.
Preliminary results from this analysis display that the predictive power of my
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overall approach is not altered significantly, thereby increasing further
confidence in the power of my approach. Third, acetylation might be
inhibited by adjacent PTMs (negative crosstalk), and therefore the
responsible KAT might be prevented from binding to or accessing its target
site. Finally, acetylation is a dynamic, transient modification, and thus MS
results may depend on a time-specific acetylation state whose kinetic
properties have not been adequately captured by the experimental
parameters. Of interest is the class of lysines in histones that were not
predicted by the algorithm, yet were detected by MS, and which might
indicate a different class of KATs that need special sequence surroundings. I
observed that one of these lysines, H2AK129, did not contain a full set of
flanking residues C-terminal to the lysine, which put this lysine at a
“disadvantage” compared to other lysines with a full set of flanking residues.
H2AK15 failed to overall strongly resemble the other acetylated histone
lysines in my training set by sequence, and therefore was not predicted. This
could be due to the training set containing an underrepresented number of
HATs, assuming that clusters of sequences under a single node represent
similar enzyme recognition.
In this chapter, I also addressed whether sequence surrounding an
acetylated lysine can drives HAT recognition by performing site directed
mutagenesis in vivo. My results display that in the H3A15K background,
H3K14ac decreases 3.5 fold, while H3K9ac increases almost two fold.
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H3K36me levels are dramatically affected with a twenty fold increase of the
unmodified form of H3K36. Thus, H3K14 disruption could be promoting
H3K9ac due to the steric binding of the H3K14 acetylation effector, Rsc4
(VanDemark, Kasten et al. 2007) (Figure 3.5). Similarly, H3K14 disruption
could be acting in an inhibitory manner to H3K36 di and tri methylation,
suggesting that H3K14ac is required for normal levels H3K36 methylation
(Figure 3.5). To my knowledge so far, acetylation of H3K14 by the NuA3
KAT requires prior methylation of H3K36, although the mechanism remains
to be determined (Latham and Dent 2007). My model suggests that perhaps
H3K14ac promotes H3K36 methylation by inhibition of demethylase activity,
or by post-translational modifications in the vicinity of these two marks that
are also involved in crosstalk (Figure 3.5). Further mutagenesis
experiments would have to be performed in order to fully explore this
hypothesis. Some preliminary experiments that I suggest are: (1) In
budding yeast, design a strain with the H3K14R mutation, and observe
whether H3K9ac levels decrease, and H3K36me0 and H3K36me1 levels
increase using H3K9ac and H3K36me1 antibodies via western blotting. The
result would reveal the distinct nature of the H3A15K mutation against the
H3K14R effects. (2) Make Rsc4 bromodomain mutations in WT cells, so that
H3K14 binding to Rsc4 is abolished. Observe H3K9ac and H3K36me levels
as a result; my above stated hypothesis suggests that H3K9ac would
increase as a result. These preliminary experiments could help us learn
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more about the crosstalk biology and can guide us to better understand the
orchestration of specific H3 acetylation, deacetylation, methylation, and
demethylation events.

Figure 3.5: Crosstalk Model
A. In the wildtype background, Gcn5 acetylates H3K9ac. The Rsc4 ( bromodomain ) binds
H3K14ac causing a steric occlusion of Gcn5 to acetylate H3K9.
B. In the mutant background, Gcn5 does not recognize its preferred site, and acetylates
H3K9. An inhibitory mechanism causes disruption of H3K36 di and trimethyl. Dashed lines
indicate possible crosstalk.
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One outstanding question that remains is what the algorithm presents
regarding enzyme specificity within the hierarchical tree. Does the
alignment of acetyl sites actually predict the HAT for those sites, and do
KATs have characteristic lysine containing motifs that they will target?
Through my method, I suggest that there may be an intrinsic substrate
specificity for acetyltransferases in general. Whether computational rules
can then be subgrouped into rules specific for each enzyme is a question
that I would like to address. In order to achieve this, I revisited my tight
cluster (H3K14 and H3K36), both Gcn5 dependent marks. I then ran my
algorithm against validated nonhistone acetylated proteins and traversed
these lysines through the histone-trained tree. I observed that there were
nonhistone proteins, particularly those that were Gcn5-mediated, that
clustered very tightly within a specific region of the histone trained tree
(Figure 3.6). Recently, an essential chromatin remodeling factor Rsc4 was
uncovered as acetylated at K25 in S. cerevisiae (VanDemark, Kasten et al.
2007). When I ran the Rsc4 protein against my algorithm, I noticed that
K25 clustered tightly with cluster, and thus were able to predict this
correctly (Figure 3.6) ((Howe, Auston et al. 2001), (Morris, Rao et al. 2007;
VanDemark, Kasten et al. 2007)). Interestingly, a recent study of the ISWI
protein in Drosophila reveals that it’s acetylated at K753, dependent on
Gcn5, and also has a G and P in its sequence (Ferreira, Eberharter et al.
2007)(Figure 3.6). Close analysis of the sequences under this cluster
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revealed that there was sequence identity and similarity in the flanking
residues of the lysine, and thus I was interested in whether acetylation of a
lysine is programmed by its surrounding residues and whether there were
particular residues that were critical for KAT recognition.

Figure 3.6: Sequence alignment of Gcn5 mediated substrates
Sequence alignment displaying H3K14, H3K36, ISWIK753, Cpr1K25, and Rsc4K25. I
predict that Cpr1K25 is acetylated by Gcn5, the primary enzyme for all the other substrates
in the purple box. Similar or identical residues are colored.
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Alignment of the flanking residues of the surrounding lysines within
the cluster (Figure 3.6; grey box) revealed that all four substrates have
either a S/T/Y residue and a glycine flanking the left side of the lysine nearly
at the same position. I also noticed that all four substrates have a proline in
the +2 position and a basic residue H/R/K in the +3 position (Figure 3.6).
Next, I ran all yeast proteins through my algorithm, and detected proteins
that contained a G-K-X-P sequence. One such protein was Cpr1, a peptidyl
prolyl isomerase (Arevalo-Rodriguez, Wu et al. 2004) that clustered with this
particular group of G-K-X-P sequences. Whether or not this substrate is
Gcn5 mediated will be an interesting question to answer and is something I
hope to follow up on in the future.
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Chapter 4: Domain prediction of chromatin-associated proteins
Summary
Protein domain prediction is important for protein structure determination,
functional annotation, and mutagenesis among other things. Most
eukaryotic proteins receive and process signals which are constructed in a
modular fashion from a combination of interaction and catalytic domains
(Zarrinpar, Bhattacharyya et al. 2003). These interaction domains mediate
the formation of multiprotein complexes that restrict signaling proteins to
appropriate subcellular locations and help determine the specificity of
enzyme-substrate interactions. Thus, being able to identify these domains
using computational and structure based approaches is an important
precursor for a range of methods. While Chapters 2 and 3 were focused on
“writer” recognition, in this chapter I discuss “readers” or effector domains
that specifically bind PTMs, and describe computational approaches used to
predict additional unannotated or cryptic domains. I focus on the chromatinassociated Polycomb Group (PcG) proteins, since these proteins contain
highly conserved key domains throughout evolution, yet their substrate
specificities are highly dissimilar contributing in part to their protein
complexity. Being able to predict additional domains and motifs outside of
the key domains could help gain insight into their functional versatility.
Since PcG proteins have diverged significantly from their Drosophila
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counterparts and from their paralogs, I use my domain detection approach
to infer co-evolution and expansion of these proteins in closely related and
distant organisms. In the first part of the chapter, I present the
diversification of PcG homolog genes in the context of development and
cellular differentiation in species ranging from plant to human, as part of a
collaboration with two of my Allis lab colleagues, Sarah Whitcomb and Emily
Bernstein (former member of Allis Lab). In the second part of this chapter, I
use existing bioinformatic methods to discover additional chromatinassociated effector proteins that bind PTMs. These effectors can potentially
be important for downstream signaling and recruitment events.
Results
Conservation and diversification of PcG homologs
I developed a bioinformatics method to discover key domains of PcG
homologs. Key domains of PcG homologs are highly conserved between
evolutionarily distant organisms (orthologs) and among paralogs in a given
organism (typically >75% amino acid similarity). However, outside of key
domains, PcG proteins have diverged significantly from their Drosophila
counterparts and from their paralogs. An important challenge is to
understand the functional significance of developmentally regulated
expression of orthologs and how this impacts PRC composition, genomic
targeting and/or mechanism of transcriptional repression. To illustrate the
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functional diversification of PcG paralogs, I focused on homologs of
Drosophila Pc, Psc, dRing and E(z).
The bioinformatics algorithm that I developed consisted of the
following steps: (1) Selection of E(z), Pc, dRing and Psc as the PcG
reference set: the “writer” (E(z)) and the “reader” (Pc) of the H3K27me
mark, the only other known catalytic member of the PcG (dRing), and
dRing’s associated factor (Psc). Sequence and domain information was
retrieved for Drosophila, mouse, and human PcG proteins from the
Swissprot, Uniprot, Ensembl, and SMART (Ponting, Schultz et al. 1999)
databases. (2) In order to identify putative homologs of these proteins in
other organisms, I performed BLAST searches using the Drosophila, mouse
and human proteins as queries (Altschul, Gish et al. 1990; Altschul, Madden
et al. 1997). The Blastp searches, using the NCBI web server
(http://www.ncbi.nlm.nih.gov/BLAST) were performed at low, medium, and
high stringencies to obtain all possible proteins in the following organisms:
Arabidopsis thaliana, Caenorhabditis elegans (worm),Strongylocentrotus
purpuratus (sea urchin), Danio rerio (zebrafish), Xenopus laevis (frog),
Gallus Gallus (chicken), Canis familiaris (dog), Mus musculus (mouse), and
Homo sapiens (human). Since homologous domains between species were
very well conserved, variation of BLAST parameters such as gap costs and
substitution matrices did not significantly alter my results. (3) I developed a
custom made algorithm to query motifs less than 15 amino acids in length
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such as the Pc box. Sequence similarity between homologous domains and
full-length sequences was used to compute a weighted score by multiplying
a fixed weight to the BLAST score and computing an overall weighted sum.
Key domains for PcG proteins were identified including: the chromodomain
and Pc-box for Pc homologs, the RING domain for Psc and dRing homologs,
and the SET and SANT domains for E(z) homologs (Figure 4.1). A list of
putative homologs containing the highest scores was compiled for each class
of PcG proteins, and homologs in different species were selected by manual
inspection. (4) Finally, the ClustalW (Thompson, Higgins et al. 1994)
program was used to cluster putative homologs to ensure that proteins with
similar key domains with minor amino acid differences such as Ring1A and
Ring1B were categorized correctly. In addition, a reverse BLAST of all the
putative homologs was also performed against the Drosophila genome to
ensure that the forward BLAST hit was accurate. Many databases of
translated cDNA libraries are inherently incomplete, and so gene sequences
of those PcG homologs that were found to be absent in a given organism
were also queried against the predicted ORFs from that organism’s genome.
Finally, putative PcG homologs were mapped onto a phylogenetic tree of
organisms (Figure 4.2). Additional potential paralogs of dPsc were found in
Drosophila through the algorithm. These proteins are Su(z)2 and l(3)-73Ah;
however as they are not well characterized as functional Psc homologs, they
have been excluded these proteins from the phylogenetic tree. Sequence
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alignments in Figure 4.3 were constructed using the Emboss program and
CEC-1 was predicted as a putative Polycomb homolog because of its high
sequence similarity with Drosophila and mouse Cbx8 chromodomains. Two
stretches of amino acids within the N-terminus and C-terminus of CEC-1 also
shared a strong sequence similarity with the Drosophila and mouse Cbx8 Pc
boxes. In Figure 4.2, the ClustalW program was used to create a multiple
sequence alignment of Cbx proteins and subsequently fed into the PHYLIP
software program (Felsenstein 2008). The protdist and neighbor joining
programs within PHYLIP were used to construct the Cbx paralog tree
(Figure 4.3) and the Emboss local alignment program was used to
determine sequence similarity and identity percentages.
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Figure 4.1: Domain and motif structure of selected PRC1 proteins
Comparison of domain and motif structure of selected PRC1 proteins in Drosophila (boxed),
human, mouse, dog, chicken, zebrafish, frog, nematode and sea urchin. Protein lengths are
scaled exclusively within homolog groups, not among paralog groups, and are represented
by a black line. Numbers shown above domains are percentage similarity to the domain in
the Drosophila homolog. Numbers to the right of proteins represent percentage similarity to
the full-length Drosophila sequence and the number of amino acids in the protein. Note the
high percentage similarity between domains, but low percentage similarity of full-length
sequence, between the Drosophila protein and its homologs in other organisms. Also note
different amino acid lengths of paralog groups (e.g. Cbx4 versus Cbx7) and different domain
structure (e.g. Cbx2 versus Cbx4). See text for details. Pc homologs are grouped based on
their sequence similarity to mouse Cbx2, Cbx4, Cbx6, Cbx7 and Cbx8. Putative C. elegans
Pc protein is shown at bottom (CEC-1). Psc homologs are grouped based on their sequence
similarity to mouse Bmi1 and Mel-18. Homologs of dRing are grouped based on their
sequence similarity to mouse Ring1A and Ring1B. Sea urchin Ring is equally similar to
mouse Ring1A and Ring1B, and is listed separately at the bottom. Abbreviations: c, chicken;
d, dog; h, human; m, mouse; n, nematode; s, sea urchin; xl, frog; z, zebrafish. Image
directly from (Whitcomb, Basu et al. 2007).
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Figure 4.1
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Figure 4.2: Domain and motif structure of selected PRC2 proteins.
Comparison of domain and motif structure of selected PRC2 proteins; see 4.1 for details.
E(z) homologs are grouped based on their sequence similarity to mouse Ezh1 and Ezh2.
Arabidopsis E(z) homologs are listed separately on the right. Abbreviations: a, plant; c,
chicken; d, dog; h, human; m, mouse; s, sea urchin; xl, frog; z, zebrafish. Image directly
from (Whitcomb, Basu et al. 2007).
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Pc homologs
Results indicate that: vertebrate model organisms have between three and
five Pc homologs [known as Chromobox (Cbx)], which all have highly
conserved CDs and Pc boxes (Figures 4.1, 4.2). However, paralogs differ
greatly in length, such as Cbx7 with a protein length of approximately 200
amino acids; these factors might contribute to differential function (Figures
4.1, 4.2). Cbx proteins also specifically interact with non-PcG proteins.
Cbx4 is the only member of the family that binds the transcriptional corepressor C-terminal binding protein (CtBP) (Sewalt, Gunster et al. 1999).
Cbx4 is also unique among Pc homologs as an E3 SUMO ligase (Kagey,
Melhuish et al. 2003). The full range of Cbx4 SUMO targets is unknown, but
the sumoylation of several transcriptional regulators, including CtBP, is
enhanced by Cbx4 (Kagey, Melhuish et al. 2003), (Roscic, Moller et al.
2006). Additionally, recent biochemical data suggest that the five
mammalian Cbx proteins have different histone-binding preferences: the
Cbx CDs bind differentially to H3K27me3 and H3K9me3, unlike Drosophila Pc
CD, which prefers H3K27me3 (Bernstein, Duncan et al. 2006).
Psc homologs
Mel-18 and Bmi1 (two of six Psc homologs in mammals; Figure 4.2) are
also likely to be non-redundant paralogs, despite their 63% amino acid
sequence identity. These proteins overall have a low sequence similarity to
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their Drosophila Psc homolog (12%). Bmi1- and Mel-18-deficient mice
display similar but distinct phenotypes (Akasaka, Kanno et al. 1996) and
(van der Lugt, Domen et al. 1994), and only

30% of Bmi1-regulated genes

were found to be co-regulated by Mel-18 and vice-versa (Wiederschain,
Chen et al. 2007). Interestingly, sea urchin does not have a serine-proline
rich domain.
dRing homologs
Vertebrate homologs of dRing, Ring1A and Ring1B, also exhibit some
functional divergence (Figure 4.2). Although they share long stretches of
high conservation (approximately 100%), Ring1A- and Ring1B-deficient mice
have drastically different phenotypes (Madireddi, Coyne et al. 1996).
E(z) homologs
The mammalian organisms that I focused on have two E(z) homologs: Ezh1
and Ezh2 (Figures 4.1, 4.2). Little is known about the functional
differences between these paralogs in mammals, but the ancestral E(z) gene
also expanded in plant lineages (Figure 4.1). Arabidopsis has three E(z)
homologs: MEDEA (MEA), CURLY LEAF (CLF), and SWINGER (SWN) with
largely non-overlapping patterns of expression (Goodrich, Puangsomlee et
al. 1997). CLF is the only protein among Arabidopsis that does not contain
an E(z) domain.
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Vertebrates vs. Invertebrate Evolution
A common mechanism of evolution is gene duplication and subsequent
divergence of coding sequences or regulatory elements. Based on the
bioinformatics analysis, PcG genes are likely to have undergone multiple
duplication events in their evolutionary history (Figure 4.2). Perhaps the
most dynamic period was during the evolution of vertebrates from
invertebrate ancestors. The extant invertebrates, Drosophila and sea urchin
have single copies of the PcG proteins in the reference set, with the
exception of Psc (Figures 4.1, 4.2). By contrast, vertebrate species have
multiple paralogs of most PcG members (Figure 4.2). One striking example
of PcG expansion is the Pc family. Represented by a single gene in
invertebrates, there are up to five Pc homologs in vertebrates with
differences in domain structure and biochemical properties (see below;
Figures 4.1, 4.2). This could be due to massive gene duplication and exon
shuffling.
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Figure 4.3: Phylogenetic representation of selected organisms and their PcG
homologs.
A phylogenetic tree of selected model organisms from plants to humans is shown (adapted
from http://www.tolweb.org/tree/). This tree illustrates that PcG-encoding genes have
undergone multiple duplication events through evolution; the most dynamic period appears
to be during the evolution of vertebrates from invertebrates. PRC1 components seem to
have been lost in C. elegans. However, CEC-1 might be a functional PRC1 homolog (see text
for details). Drosophila proteins, used (here and in the text) as the PcG reference set, are
highlighted in the red box. Shaded boxes next to each organism display homologs of E(z)
(red), Pc (orange), Psc (blue) and dRing (green) proteins in each organism. Red slash
marks represent probable gene expansion events. The black and grey nodes represent the
common ancestor of all selected model organisms and extant bilateral animals, respectively.
The light blue and dark blue nodes denote the common ancestor of extant vertebrate and
mammalian species, respectively. Parentheses denote proteins with biochemically or
genetically defined PcG activity but lacking sufficient sequence conservation with the
Drosophila, mouse or human proteins to be predicted as homologs by methods used.
Brackets indicate putative PcG proteins that were identified by sequence similarity but that
need to be confirmed functionally. Asterisks represent proteins that might have multiple
(putative) paralogs within a given organism. Note that branch lengths do not represent
evolutionary distance between organisms.
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Prediction of a putative Pc gene in C. elegans
My analysis uncovered a putative Pc homolog in C. elegans, previously
identified as C. elegans chromobox 1 (CEC-1) (Agostoni, Albertson et al.
1996). Little is known about CEC-1 except that it localizes exclusively to
somatic nuclei and dissociates from chromosomes at mitosis (Agostoni,
Albertson et al. 1996). The domain structure of CEC-1 supports its
classification as a Pc homolog: an N-terminal CD and a C-terminal Pc box (as
well as a second putative Pc box after the CD) (Figures 4.1,4.3). Although
the sequence similarity between full-length CEC-1 and dPc or dHP1 are equal
(27%), CEC-1 lacks two important sequence characteristics of HP1 proteins:
a chromo-shadow domain and a stretch of glutamic acid residues N-terminal
of the CD (Figure 4.3). The possibility that CEC-1 might regulate
H3K27me-dependent gene repression in the worm soma is intriguing but
requires further investigation.
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Figure 4.4: CEC-1 sequence alignment and phylogeny of mouse Cbx proteins.
A. Sequence alignment is shown between the chromodomains (CD) and Pc boxes of dPc,
mouse Cbx8 and CEC-1 proteins. An asterisk represents aromatic residues within the
chromodomains that are required for histone methyllysine binding. Pc-box-like features are
found in both the N-terminal and C-terminal regions of CEC-1 and are aligned individually to
the Pc boxes of dPc and mouse Cbx8. (N) and (C) represent the N-terminal and C-terminal
Pc-box-like features of CEC-1, respectively. Amino acids highlighted in red represent
residues that are identical to each other, and those highlighted in blue represent residues
that are evolutionarily similar. Overall, the bioinformatics analysis suggests that CEC-1
might represent a Pc homolog, rather than a HP1 homolog. However, this remains to be
rigorously tested.
B. Pairwise sequence similarities were calculated between all mouse Pc proteins (Cbx 2,
Cbx4 and Cbx6–Cbx8) and an unrooted neighbor-joining tree was constructed using the
PHYLIP software program (http://evolution.genetics.washington.edu/phylip.html).
Evolutionary distance between paralogs is represented by the tree branches, which are
drawn to scale. The table below shows percentage sequence identity and percentage
sequence similarity between the chromodomains, Pc boxes and the full length sequences of
Cbx2 and Cbx8 proteins. These proteins were selected for comparison because of their
comparable length and evolutionary distance. Note the high similarity and identity between
key domains, but significantly less similarity and identity in the full length sequences.
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Figure 4.4
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Predicting chromatin–associated effector proteins
Chapter 2 illustrates how acetylation has shown to be important for cellular
function, and why being able to predict and map these marks is an essential
first step in the discovery process of higher level regulatory pathways. Of
paramount importance is the ability to uncover effector proteins that bind
PTMs, as they serve as another layer of regulation in many cellular
processes. Examples of additional effector proteins that bind to posttranslationally modified amino acids are Plant Homeo Domain (PHD) finger,
bromodomains (BD) (acetyl-lysine binding), chromodomains (CD) (methyllysine binding), and Src-homology 2 (SH2) domains (phospho-tyrosine
binding), all which have been studied thoroughly. However, there likely
exist a number of unidentified proteins containing cryptic versions of these
domains or similar domains that have eluded detection by conventional
bioinformatic analysis, thus additional studies of effector domains are
required to identify these proteins and their functional relevance.
My interest in this project developed as a result of Allis lab colleagues
and I extensively using the SMART/PFAM (Bateman, Coin et al. 2004)
domain prediction programs and recognizing that certain domains that we
considered as putative effectors by sequence/structure-gazing were not
contained in either the SMART/PFAM databases, for example p300, a lysine
acetyltransferase (personal communication, A. Ruthenburg) containing a
117

putative PHD finger domain. Manual screening of effector proteins that were
not predicted by PFAM/Smart, together with domain querying of PcG
proteins with limited results, led us to invest in a project aimed at
discovering additional effector proteins.
I hypothesized that software programs such as SMART and PFAM were
often limited in their domain predictive ability due to default parameters
usage in within all features of the protein. For example, loop structure,
although more flexible than other regions a protein fold, such as the α-helix,
or β-strand, obtains an identical gap penalty score as the other structured
elements of the protein. A tight conservation between loops within an
alignment is less essential than conservation between the structured regions
of the protein, since the binding pocket frequently resides on the surface of
the protein ensconced within well-ordered secondary structural motifs.
Moreover, gap penalties contribute to the overall score of alignments, and
therefore, the size of the gap penalty relative to the entries affects the
alignment that is finally selected. Though previous bionformatic/structural
studies have used a similar loop adjustment method in protein finding
analyses (Qiu and Elber 2006), I wanted to focus on applying this method to
PTM effector proteins for the benefit of our lab and the chromatin community
at large.
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Training set, key assumptions, and method
In order to begin my computational analysis, I collected all sequences of
known effector proteins BD, CD, SH2, and PHD finger containing sequences
found in the SMART database. The SMART database contains more than 500
domain families found in signaling, extracellular and chromatin-associated
proteins. These domains are extensively annotated with respect to phyletic
distributions, functional class, tertiary structures and functionally important
residues. The number of human training sequences in each of these
respective domains was: BD (99), CD (70), SH2 (192), and PHD (256). I
next performed a multiple sequence alignment (ClustalW) on all training
sequences through three step process (Figure 4.5): 1) I used JPred, a
secondary structure prediction program (built from a consensus of multiple
prediction methods) (Cuff, Clamp et al. 1998) in order to label the loop
element(s) in my sequences. 2) Applied a less rigid gap penalty exclusively
in the loop region of protein, while applying a harsher penalty ( default
PFAM parameters ) on the more rigid areas 3) Apply the same gap penalty
to the entire length of the proteins in the alignment. Next, I fed the loopadjusted and unadjusted version of the sequence alignment into the Hidden
Markov Model 2.0 (HMM), a statistical model in which the system being
modeled is assumed to be a Markov process with unobserved state.
Running the HMM against MSA resulted in an output of additional effector
proteins with an accompanying E-value. The resulting alignment is the
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alignment between the consensus sequence which is derived from highest
residue frequency at each position in the MSA and the predicted effector
domain.

Based on PFAM’s threshold of selection, the E-value is the number

of hits that would be expected to have a score equal or better than this by
chance alone. A good E-value is much lower than 1, and measures
statistical significance. In my analysis, I used an E-value <= .01 to threshold
my boundary. After running my model against the human proteome, I
manually scanned the list of proteins that were not annotated in literature
with the desired domain, but which contained a maximum number of
residues that were critical annotated for PTM binding. As a final step of
verification, and work which is in progress, I analyze the known structures of
the predicted effectors in order to ensure sure that the predicted effectors
are homologous to the canonical structure.
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Figure 4.5: Schematic of domain prediction method
Proteins with known effector domains (chromodomain, bromodomain, etc.) are separated
by their secondary structure elements such as helix, loop, and beta strand. Loops within the
proteins are given a less stringent gap penalty than the highly conserved regions in the
protein such as the helix within the multiple sequence alignment. The alignment is fed into a
Hidden Markov model (HMM) and then subsequently, the HMM produces an output of
additional effector proteins.
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Via my method, I was able to predict additional effector proteins
containing all the domains I have specified above. I compiled a list of 7
putative candidates in the human and S. cerevisiae proteomes that contain
previously unannotated BDs, CDs, PHD fingers, or SH2 domains, respectively
(shown in figures below). Capital letters in the alignment represent
residues that are aligned to the consensus. Small letters represent residues
that HMM arbitrarily assigns based on a probabilistic function of residues in
the alignment. For validation purposes, I used the few literature validated
effector proteins that were excluded from my training set to assess whether
my method was promising, particularly for PHD predictions.
PHD finger predictions
At the time of my analysis, several of my predicted PHD finger proteins were
not annotated in literature as PHD finger containing proteins, but have now
been experimentally validated, and published. These include DNMT3 (Ooi,
Qiu et al. 2007), RAG2 (Matthews, Kuo et al. 2007), ATRX (Baker, Allis et al.
2008) and others. In some cases the PHD finger domains appeared atypical
by amino acid sequence, particularly for RAG2, which has an atypical
aromatic cage, and an extremely divergent loop region (Figure 1.7B). In
the case of RAG2, I achieved an E value of 0.5 before loop adjustment, and
an E value of 10e-12 after loop adjustment, which is much lower and of
higher statistical significance. My finding is consistent with the finding that
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RAG2 PHD finger behaves like a canonical H3K4me3 effector (Matthews, Kuo
et al. 2007). Figure 4.6 displays the alignment between the consensus HMM
sequence (see Methods for determination) and the novel predicted PHD
finger sequences (EP300, SNF2), those that are currently not in the
database. Aromatic cage residues are highlighted as these are H3K4me3
recognition residues, as well zinc- coordinating residues. Interestingly, many
of the predicted PHD finger proteins also contained bromodomains (shown
below the alignment of the proteins in Figure 4.6).
Bromodomains
In humans, I predicted two BD containing proteins, MLL2 and SP110 and in
yeast I predicted Arp8, an actin related protein involved in chromatin
remodeling (Figure 4.6). Among all of these, a promising bromodomain
candidate protein was Arp8 (E-value=0.01) (Figure 4.6). This was also a
compelling candidate because it was a yeast protein, where experiments
could be facilitated by commercially available strains. Intriguingly, it also
contained an important asparigine residue in a conserved histone binding
acetyl-lysine position (in red). To determine whether the predicted BD in
Arp8 could bind to acetylated lysine, I performed a yeast peptide-pulldown
experiment using a commercially available tap-tagged strain of Arp8. The
preliminary experiment shown in Figure 4.7B suggests that Arp8 binds
selectively to acetyl peptides H3K4me3K14ac and H3K4me3K9ac, but not to
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H3K56ac. Next, I cloned and recombinantly expressed full length Arp8 to
determine whether Arp8 itself, or a possible complex member was
responsible for peptide binding (data not shown). I was successfully able to
achieve cloning of full length Arp8, however further experiments would be
required to complete the experiment by cloning the bromodomain itself, and
then subsequently repeating the peptide binding assay using additional
unmodified and acetyl peptides.
Chromodomains
The next group of proteins that I predicted are CD-containing proteins, a
family containing different subgroups classes of proteins. The first class
includes proteins having an N-terminal chromo domain followed by a region
termed the chromo shadow domain, eg. Drosophila and human
heterochromatin protein Su(var)205 (HP1). The second class includes
proteins with a single chromo domain, eg. Drosophila protein Polycomb (Pc);
mammalian modifier 3; human Mi-2 autoantigen and several yeast and
C.elegans hypothetical proteins. In the third class, paired tandem chromo
domains are found, eg. in mammalian DNA-binding/helicase proteins CHD-1
to CHD-4 and yeast protein CHD1. The training set included a conflation of
all the CDs found in PFAM, and were not separated individually by family. I
found two candidates (SMRC1 and MRG1), with the most promising
predicted candidate, SMRC1, which appears most similar to the
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chromodomain protein Cbx2 (E =5.3e-7) among all other CD containing
proteins in the training set. Also, SMRC1’s sequence similarity to is HP1 (E=
5e-6), which is also statistically significant.
SH2
SH2 domains are modules of ~100 amino acids that bind to specific
phospho-tyrosine (pY)-containing peptide motifs. In yeast, the only known
protein with a SH2 domain is SPT6, a transcriptional elongation protein.
However, there is no known function associated with the SH2 domain. My
analysis led me to discover a SH2 domain containing protein, Ste6, a mating
pathway protein in yeast (E=5.2e-7).

125

Figure 4.6: Effector Protein Predictions
An alignment is shown between the consensus domain sequence and the predicted effector
protein. Domain predictions displayed are the following: PHD, CD, BD, and SH2. Residues
that are identical between sequences are shown. Underlined residues are those that are
critical for histone binding. E value is shown for the predicted proteins as well as the
residue positions in the predicted protein. Capital letters in the consensus sequence show
that this residue is highly conserved, whereas the small letters represent residues that have
been inserted via probabilistic method. Sequence similarity and identity (%) between the
consensus and predicted protein is shown in the red box. Shown below alignment are the
other domains in the protein as annotated in the SMART database.
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Figure 4.6
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Figure 4.6 (continued)
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Figure 4.7: Peptide binding assay using Arp8 whole cell extract.
A. Schematic of a peptide pulldown assay. The peptide is shown with either an acetylated
mark or as unmodified. When incubated with Arp8, the question is whether binding occurs.
B. Shown are peptides H31-20 unmodified, H31-20 with H3K4Me3, H31-20 with
K4Me3K9ac, H31-20 with H3K4Me3K14ac, H348-63 with K56 unmodified, and H348-63 with
K56ac. Pulldown assay was performed with a DALK protein-A antibody and bands represent
binding between the whole Arp8-TAP tagged and the respective peptides.
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Chapter 4 Discussion
The phylogenetic tree (Figure 4.2) argues that PcG genes underwent
multiple duplication events in the evolution of plants and animals. One
possibility for this is that these extra genomic copies diverged in sequence
resulting in differential functions conferring fitness advantages. Here, the
focus was on PcG gene expansion events, but I suspect that PcG proteins
were also lost from genomes. A thorough comparative genomic analysis of
loss and expansion from genomes can help us delve further into which genes
were deleted through mechanisms of translocation or chromosomal
inversion.
An outstanding question in the Polycomb/trithorax field is how these
transcriptional regulator complexes are localized to specific genes in a tissue
specific manner. In Drosophila, DNA elements known as PRE/TREs
(Polycomb/trithorax response elements) have been mapped near the TSS of
a handful of PcG/trxG target genes, and have been shown to be essential for
proper PcG/trxG localization and expression of these genes. Attempts have
been made to discover and map functional PRE/TREs in Drosophila using
genomic, microarray, ChIP, and bioinformatic techniques. These studies
identified a total of 167 novel PRE/TREs, some of which mapped to genes
involved in development and cell proliferation (Ringrose, Rehmsmeier et al.
2003).
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Unfortunately, the sequence characteristics of putative PRE/TREs in
mammals have remained elusive. However, new technology such as ChIP
coupled to Solexa sequencing has produced large, genome wide data sets
relating to PcG occupancy and target gene expression. I present an
extension of the Ringrose study that I propose in order to predict PREs in the
human genome (Ringrose, Rehmsmeier et al. 2003). A brief outline of this
is as follows: (1) use the current Drosophila annotated PRE data (167
sequences) to create a computational model for training purposes. Utilize
empirical methods (supervised or unsupervised clustering) to learn about
sequence constitution of known PRE elements. There could be multiple
methods, but training and testing on the 167 elements themselves (using
cross validation) could be an initial pilot to assess baseline accuracy. (2) Run
the algorithm against the mammalian genome and make high quality
predictions that can be tested in-vivo. (3) Perform ChIP experiments with
PcG antibodies, and/or mine datasets already published to validate target
DNA elements. It would be interesting to observe if validated mammalian
PRE/TRE map to promoter regions as Ringrose and others observed in
Drosophila. Identifying mammalian DNA elements necessary for PcG/trxG
localization, if they indeed exist, would be an important step towards
understanding tissue-specific epigenetic maintenance of both activated and
silenced states.
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Unmodified H3K4me0 vs. H3K4me Effectors
Several papers have recently shown PHD finger-containing proteins binding
H3K4me0. Recent studies display that DNMT3L, BHC80, TAF3, and AIRE
among others bind H3K4me0 (Lan, Collins et al. 2007; Ooi, Qiu et al. 2007;
Koh, Kuo et al. 2008; van Ingen, van Schaik et al. 2008). Co-crystal
structures of these proteins with the H3 tail reveal crucial residues mediating
this recognition. For example, the basis for binding of H3me0 to DNMT3L is
the steric occlusion of the aspartic acid 90 in DNMT3L and H3K4me2/3
(Figure 4.8A). Other studies have revealed that the salt bridge between
the unmodified lysine on H3 and acidic residues on the effector are crucial
for favorable enthalpic contributions to binding free energy. Recently, the
Yang Shi and Xiodong Cheng’s groups showed that substrate specificity of
the BHC80 PHD finger is determined primarily through the recognition of the
H3 amino terminus, H3K4 and H3R8, and the three main chain carbonyl
oxygen atoms (residues 523, 524 and 525) on BHC80 that form a hydrogen
bond ‘cage’ that recognizes the N terminus of H3 (Lan, Collins et al. 2007).
Molecular recognition of the unmodified lysine is primarily through bonds to
the unmodified epsilon amino group and steric exclusion of appended methyl
groups, where a second or third methyl group would engender steric clashes
with the D489 carboxylate, the amide carbonyl of E488, and the β-carbon of
the H487 side chain (van Ingen, van Schaik et al. 2008). Additional motifs
include a Proline-(x)-Glycine -x - Tryptophan motif before the last pair of
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Cysteines (Figure 4.8B in blue, c-terminal). Figure 4.8 is an alignment of
the current list of H3K4me0 binders.
In order to predict additional effectors using my method, I use the
training method described above to predict new unmodified H3K4 binders,
and use the known H3K4me0 as my training set of sequences (Figure
4.8B). Even though the training set is small (only five sequences), there
are a number of conserved residues in these proteins, and for further
screening of H3K4me0 binders, I manually scanned for proteins with these
residues in the conserved positions. In my list (Figure 4.8C), many of the
predicted proteins are either published or are being worked on by other
groups, such as DNMT3, JARID1A, and AIRE (Ooi, Qiu et al. 2007; Koh, Kuo
et al. 2008; Wang, Song et al. 2009). The published list of proteins gives
me confidence that using more sophisticated methods, additional effectors
can be discovered which could be regulatory in nature.

133

Figure 4.8: H3K4Me0 Known and Putative Effectors
A. (Left) Interaction between the H3 N terminus (amino acids in magenta) and DNMT3L (in
black). Dashed lines indicate potential interactions between amino-acid side chains. H3K4
makes contacts with DNMT3L. D90 and D88 and methylation of K4 will occlude these
interactions. (Right) Mutagenesis of residues (tick marks on left) of DNMT3L abolished
binding. Image adapted from (Ooi, Qiu et al. 2007).
B. Alignment of all known H3K4Me0 binding proteins. Yellow represents identical residues;
blue represents similar patches of residues. Alignment constructed using ClustalW.
C. Predicted H3K4me0 binders (gi annotation to the left) with E-value resulting from Hidden
Markov Model output are shown the right of the predicted protein.
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Figure 4.8
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Taken together, the studies I performed in this chapter reveal that
there are still a number of undiscovered protein domains. Improved
algorithms, more accurate prediction modeling, and higher throughput
evolutionary analysis can benefit multi-domain classification problems, and
potentially mitigate the gap between the various domain definitions.
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Chapter 5: General Discussion
A rapidly growing literature suggests that acetylation in histone and
nonhistone proteins is important for a number of biological processes,
including cellular differentiation, DNA binding, and other chromatintemplated processes. In the previous chapters, I have discussed my work
developing a computational model that will enable the scientific community
to characterize and map putative acetylation sites in any protein of interest.
I have also shown using my model that we can predict acetylation sites in
both histone and nonhistone proteins. Furthermore, I have shown that there
are potentially key residues that are essential for acetyltransferase
recognition, and that acetyltransferase activity might be regulated via
crosstalk between modifications on the H3 tail. My computational model and
results represent a step towards gaining a framework for predicting lysine
acetylation sites in both human and yeast proteomes. It will be of interest in
future studies to see whether our algorithm is capable of predicting lysine
acetylation sites in other organisms. Below I will discuss some of the
implications of my work.
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Enzyme prediction and discovery
Elegant structural studies by the Marmorstein group have shown that
specific residues within KATs (Gcn5, Esa1) that form contacts between the
enzyme and substrate are conserved among organisms (Marmorstein and
Roth 2001). My algorithm agrees with the importance of these conserved
residues, yet I was limited by the quantity of structural information
available. Further structural analysis of various KAT-substrate relationships
would allow us to determine whether the rules that we have observed are
general acetyltransferase rules or enzyme specific principles. However,
structural studies remain experimentally challenging and low-throughput by
nature.
Alternatively, my prediction algorithm might be improved through
additional experimental determination of KAT-substrate specificity, this in
turn leading to an improved training dataset. To achieve a deeper
understanding of KAT enzymes and their substrate specificity proteomewide, I could perform the following experiments: first, on a small scale to
establish the assay, and then-genome wide, I would design two identical
proteome arrays containing histones H3, H4, and bovine serum albumin
(BSA) as a negative control. Each array would then be incubated with
radiolabeled acetyl-CoA and either of the histone acetyltransferases Gcn5 or
Esa1, respectively. The array would then be subjected to fluorography, and
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a positive result would entail Gcn5 labeling H3, and Esa1 labeling H4
(Figure 5.1A). I would not expect to see a signal in the BSA lane. If my
pilot arrays confirm the expected results, I could carry out this experiment
on a proteome-wide scale.
Further testing on magnified scale would involve protein microarrays
containing 5800 yeast proteins incubated individually with all known yeast
HATs (currently there are seven). Detection of incorporated radiolabeled
acetyl-CoA would result in a number of possible KAT substrates. These
substrates would then be validated from individually TAP-tagged lines. First,
all acetylated proteins would be immunoprecipitated (IP) using a monoclonal
pan-acetyl-lysine antibody (there are several commercially available). The
presence of the potential HAT substrate would then be probed by
immunoblotting with an anti-TAP antibody. Mass spectrometry would then
be used to map the position of the acetylated lysine on the protein. A
similar study was published recently by the Shelley Berger lab revealing
NuA4’s substrate specificity (Krishnamoorthy, Chen et al. 2006) (Figure
5.1B). A follow-up gene ontology (GO) analysis could indicate pathways or
subset of pathways that the candidate acetyl proteins are enriched for.
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Figure 5.1: Proposed discovery of novel KAT substrates
A. Proteome-wide microarray of enzymatic discovery of substrates. In step 1, develop pilot
protein array with H3 and H4 on the array. Incubate array with Gcn5 and Esa1. Once
controls have been tested, include all 5800 proteins per array, and incubate array with each
enzyme separately. Black boxes represent putative acetylated proteins as result of this
assay, which become candidate substrates. An immunoprecipitation of substrates with panacetyl antibody followed by a TAP tag purification and subsequent MS/MS analysis could be
performed to map the acetyl site.
B. Example of an array which includes 5800 proteins on an array. Acetylated substrates that
were detected were Pck and Cdc34 among others (Lin, Lu et al. 2009).
C. Proposed computational model. Substrates with identical enzyme could potentially cluster
together, and a separate tree could be built for all 8 KATs in yeast.
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Figure 5.1
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The results of these experiments could allow me to add enzymatic
information onto the hierarchical tree (Figure 2.2), which could add
predictive power to my algorithm. Potentially, these results would help
uncover enzyme specificity for nonhistone acetyl substrates. I would expect
substrates of the same KAT to cluster in my analysis, therefore if a substrate
of an unknown HAT clusters tightly with a substrate of known HAT activity, I
would expect these two to be substrates of the same HAT. This procedure
could help narrow down whether there are specific clusters designated by
enzyme, or whether there are acetylation rules in general, so that we can
gain a further predictive understanding of our targets (Figure 5.1C).
Furthermore, this experiment would allow me to gain insight into residues
that are critical for specific enzyme recognition, which could ultimately feed
back into the algorithm by changing the weight function of flanking residues.
In Chapter 3, I discussed my aim to induce methylation on H3K14 by
mutagenizing residues in vivo to emulate the flanking residue profile of
H3K36, a famous di and tri-methyl site. However, little is known about
methyltransferase specificity and enzyme recognition. My initial
computational analysis of methylation substrates displayed that a strong
consensus sequence or signal was not present among the flanking residues
of methyl-lysines, possibly due to limited experimental data. This could be
due to the fact that methyltransferases have different selectivity
mechanisms and that we may be underfitting the data by studying a
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conflation of these substrates. Using the same protein microarray as for
acetylation, methylation could also be studied by incubating the microarrays
with radiolabeled S-adenosylmethionine (SAM) and various
methyltransferases. Further computational analysis and more defined
datasets could allow us to explore methylation rules as well.
Crosstalk of modifications on the same histone tail domain
To my knowledge thus far, there have been few studies that have rigorously
computationally or experimentally tested the necessity of specific flanking
residues in maintenance of an acetyl mark. My results in Chapter 3
demonstrate that the flanking residue mutations of H3K14 can initiate
crosstalk that can potentially occur between modifications on the same tail.
It has been previously shown that acetylation of a particular lysine can be
inhibited by adjacent PTMs (negative crosstalk), with the implication that the
responsible KAT might be prevented from binding to or accessing its target
site (Yang and Seto 2008). My mutagenesis studies on the flanking residues
of H3K14 suggested that there could be a longer range crosstalk occurring
between H3K14, H3K9, and H3K36, and perhaps these modifications are
inhibitory to each other in some manner. Briefly, I observed that upon
mutation of H3A15 to a lysine, H3K14ac levels decreased approximately 4
fold, while H3K9ac levels increased by two fold. H3K36me0 and H3K36me1
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levels soared, while H3K36me2 and H3K36me3 decreased by approximately
1.5-2 fold.
To further study whether the lysine A15 is an enzyme specific residue,
I could perform the experiment in reverse: select a lysine that is low in
abundance and then mutate the “next door” residue to an alanine to
determine whether the target residue acetylation levels are stimulated.

An

ideal lysine for this experiment would be H3K36, since it is of low abundance
in yeast (Morris, Rao et al. 2007), and has a lysine (K37) adjacently
positioned. Thereafter, I would extract histones as I previously did, and
analyze their PTM levels by mass spectrometry. First, I could address
whether the acetylation of K36 increases in intensity as a result of this
mutation, and whether H3K37 is also modified (Figure 5.2B,C). Perhaps an
altered acetylation state of H3K36 would recruit an enzymatic complex which
could stimulate H3K37 acetylation or methylation states. Second, it would
be interesting to see whether H3K9ac, H3K14ac, or any of the H3K36me0,
me1, me2, and me3 marks are affected by the K37A mutation, since
crosstalk has been shown to occur previously on histone tails (Latham and
Dent 2007).

Perhaps a rise in H3K36ac levels would prevent methylation to

occur on H3K36 (Figure 5.2C), and H3K37A would carry a similar profile to
H3A15K (Figure 5.2C) (Latham and Dent 2007). Another related question
that could be asked is whether mutations in the flanking residues of H3K14
and H3K36 would alter transcriptional profiles genome-wide since all three
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marks, H3K9ac, K14ac, and K36me have a link to transcriptional activation
(Kurdistani, Tavazoie et al. 2004). My finding suggests that there might be
a distinctive role for each acetylation, and it is now possible to examine the
cross-talk of adjacent acetylation and methylation marks in vivo.
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Figure 5.2: Proposed future mutagenesis of H3K36
A. Sequence alignment of H3K14 and H3K36. Colors as in Figure 3.3.
B. Proposed mutation of H3K37 to an alanine.
C. Proposed cross-talk effect of H3K37A mutation. H3K36 acetylation levels could increase,
which could cause H3K36 methylation to decrease. H3K36 effects could regulate H3K14ac,
by inhibiting its acetylation, which could allow for Gcn5 (H3K9 KAT) to acetylate H3K9.
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Figure 5.2
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Histone variants and PTMs
Changes in the chromatin template can occur through various interrelated
mechanisms: post-translational modifications of histones, ATP-dependent
chromatin remodeling, and the incorporation (or replacement) of specialized
histone variants into chromatin (Bernstein and Hake 2006). These variants
have specialized functions and in some cases are synthesized through the
cell cycle (Bernstein and Hake 2006). While the two major human histone
variants of H3, CENP-A and H3.3, have been extensively studied, the larger
number of human H2A variants, including H2A.Z, H2A.X, and others, has
been studied relatively less. There are at present three testis-specific H2B
variants, and to date, no variants from the H4 family have been uncovered
(Bernstein and Hake 2006) (Figure 5.3, courtesy Sandra B. Hake).
Since many variants have specialized functions and unique sequences,
PTM profiles of these variants would potentially help gain a mechanistic
insight into variant function. For example, phosphorylation on the serine in
the H2A.X motif “SQ(E/D)” upon DNA damage is a phenomenon which is
conserved across species (Rogakou, Pilch et al. 1998; Downs, Lowndes et al.
2000; Stiff, O'Driscoll et al. 2004; Xiao, Li et al. 2009). Predicting additional
modifications on these proteins might help unravel further distinct regulatory
functions or pathways. I attempted to predict modification patterns on H3
variants, however, as H3 variants are dissimilar to the canonical H3 by only
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four or five amino acids, as shown in the alignment, the algorithm did not
predict any additional modifications on this variant.
Human histone variants have been studied relatively in depth,
however yeast histone variants are still an area that has not been as
intensely explored. When I ran the yeast variant Cse4 (homolog of human
CENP-A) against my algorithm, to my surprise, a protein which seems
dissimilar by “eye” to the canonical H3, had a strong similarity (80%) to
H3K56 in yeast (Figure 5.4A,B(red arrow)). Since the enzyme responsible
for yeast H3K56ac has been discovered (Rtt109/p300) (Tang, Holbert et al.
2008) and functionally deciphered, Cse4 might also acetylated by similar
HATs, which would point to a sequence conservation of K56-type substrates.
If Cse4 is indeed acetylated, one could then perform knockouts of the HATs
themselves to determine whether Rtt109/p300 is responsible for Cse4
acetylation. This would also allow one to pinpoint residues that may be
critical for Rtt109/p300 recognition.
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Figure 5.3: Schematic of mammalian histone variant proteins
Schematic representation of the mammalian histone variant proteins containing the Nterminal tails and the globular core with the C-terminal tails: (A) H2A variants (yellow), (B)
H2B variants (red), (C) H3 variants (blue), (D) H4 variants (green). Protein sequences that
are highly divergent between the conventional histone and its variants, histones are
depicted in different color shades without highlighting sequence differences. Specific amino
acids are depicted when only a few key differences are found among variants, or when
these amino acids are post-translationally modified. Residues that have been found to be
post-translationally modified are marked in the following manner: circle, phosphorylation;
square, methylation; triangle, acetylation; trapezoid, ubiquitination. The macrodomains of
macroH2A histones are not drawn to scale and are shown as triangles to highlight that
these domains are not histone-like sequences. Image adapted from (Bernstein and Hake
2006).
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Figure 5.4: H3K56 and Cse4
A. Alignment of H3K56 and Cse4 in budding yeast. Yellow highlighted residues represent
patch of similar residues in a different order in H3K56 vs. Cse4. Purple residue represents
similar amino acids, whereas red denotes identical residues.
B. Alignment of all H3 variants, hCENP-A, and yCse4. Arrows indicate H3K56 which is
conserved across variants, and Cse4K52.
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In addition to the four core histones, there is a fifth histone, linker
histone H1, involved in nucleosome structure (Figure 5.5A). These proteins
are crucial to nucleosome-nucleosome contact and higher order chromatin
structure. It is possible that post-translational modifications could regulate
their contact, causing dramatic chromatin structure changes, including
decreased global nucleosome spacing, reduced local chromatin compaction,
and decreases in certain core histone modifications. A multiple sequence
alignment of the H1 variants is shown Figure 5.5B, and as displayed these
variants are conserved in the core region, but divergent within the tail
region. To predict additional modifications as well as experimentally
validated modifications, I ran the yeast and human histone variants
including H1 against my algorithm. Interestingly, out of 5 known H1
validated acetyl sites, I was able to predict 3 with my algorithm (these
included K90, K146, and K22) (Figure 5.5B; red arrows) (Wisniewski,
Zougman et al. 2007). Notably, these acetylation sites all contained a
flanking glycine and basic residues in the vicinity as well. Further validation
of the predicted unknown modifications might lead to an important
understanding of the role of acetylation in H1 function. Finally, genomic and
proteomic studies, evolutionary analysis using bioinformatics, and
experimental approaches in model organisms will provide new insights into
the biological roles of these variant proteins.
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Figure 5.5: H1 Schematic and Predictions
A. Nucleosome made up of DNA (red), Histone octamer (black) and Histone H1 (green).
B. Alignment of all H1 variants, CENP-A, and yCse4. Arrows indicate acetylated lysines
that I predicted correctly in histone H1.
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Many questions remain as to whether acetylation, like phosphorylation, is
a key signaling mechanism for multiple cellular pathways. Mann’s study
reveals that a striking feature of acetylation is that it tends to occur in large
macromolecular complexes involved in diverse cellular processes
(Choudhary, Kumar et al. 2009). With higher throughput proteomic
datasets becoming available, we can begin to dissect the role of distinct
acetylation marks across multiple cell lines and analyze their importance in
cellular pathways, signaling, and gene regulation. Answering these
questions can help us achieve state of the art epigenetic drug therapy
targeted towards specific acetylation marks, however mapping these marks
is a critical first step. Understanding the crosstalk between acetylation and
other PTMs such as methylation and phosphorylation remains to be
answered will potentially be the subject of future research endeavors.
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Chapter 6: Materials and Methods
Acetylation (computational)
Datasets
Training set: 56 human and S. cerevisiae core histone lysine sequences
were collected from the Swissprot database http://ca.expasy.org/sprot/.
Test set: Source of nuclear protein and pan-acetyl antibody datasets are
described in Chapter 2. The budding yeast proteome-wide dataset of
observed peptides with acetyl modifications was derived from the publicly
available GPM Annotated Spectrum Library (Craig, Cortens et al. 2006) for
S. cerevisiae (v. 2008.10.1). Peptide sequences from the library
corresponding to lysine modifications (nominal modification mass = 42 Da.)
were curated and mapped onto the appropriate set of protein sequences.
Given the mass resolution of many of the spectra used to create the library,
it was not possible to distinguish a priori between acetyl-lysine versus
trimethyl-lysine on the basis of the tandem spectra alone.
Hierarchical Clustering Analysis
I performed hierarchical clustering on the sequences surrounding each of
the 56 histone lysines. All 56 sequences were aligned to each other creating
a matrix of pairwise alignment scores; the metric was based on these
pairwise scores. Sequence alignment scores were computed by performing
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BLAST local alignments using the NCBI BLAST 2.0 server. A standard
BLOSOM62 evolutionary substitution matrix was applied (Eddy 2004). The
hierarchical clustering works in an iterative process with the sequence
alignment score representing the metric value: it begins with each protein
sequence as a singleton cluster; during each iteration, it finds two clusters
with the lowest metric value, then joins these two clusters into a new
cluster, and updates the metric value between this new cluster and all
others (see text for details). An average alignment score is calculated when
there are multiple leaves under a node, thereby assigning a single metric
value to each node. As an example, H2AK127, a lysine not observed as
acetylated, and H4K12, an acetylated lysine, clustered tightly via sequence
alignment. This is illustrated by their shared node placing them to right of
the threshold line (Figure 2.2A; blue box). As a result, H2AK127 was
predicted to be acetylated via my approach. In contrast, H2BK27 clustered
with H2BK11 more weakly, and thus their shared node was positioned on
the left side of the threshold line. Hence, this lysine H2BK27 was not
predicted as acetylated.
Statistical Analysis
ROC calculations are described in main text. Hypergeometric probability
calculation: Pr=

; (N = all lysines in human proteome; K =

number of times the particular residue is seen flanking in each position in
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human proteome; n = total number of lysines in each independent validation
dataset; m = number of times the particular residue is seen flanking in each
position in validation dataset). Sensitivity (Sn) was calculated as the total
number of correctly identified acetylation sites from the positive dataset
divided by the total positive dataset. Specificity (Sp) was calculated as the
total number of negative sites that were not predicted to be acetylated
divided by the total negative dataset size. Accuracy calculated as the
number lysines correctly predicted as acetylated/total number of acetylated
lysines in dataset.
Additional Methods of Classification
When I first began the project, I used a Support Vector Machine Classifier
(SVM Light) to analyze my data (Yu, Joachims et al. 2008). I used a linear
kernel function, which measures the similarity between a pair of inputs, and
defines an inner product in the feature space. My feature space consisted of
k-mers, where k = (2..6). These k-mers were extracted from the residues
surrounding the flanking lysine. The results of this method (75% accuracy
on histone lysines, where a lysine was either classified as “validated” or “not
observed” as acetylated) encouraged me to proceed and use additional
machine learning methods empirically. Hence, I also used a mismatch
kernel (Leslie, Eskin et al. 2004), which consists of a class of string kernels
for use with support vector machines (SVMs) to measure sequence similarity
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allowing for mutations between patterns. Thus, if two protein sequences
contain many k-length subsequences that contain m, mismatches, the inner
product one would expect is large. The mismatch kernel did not alter my
results significantly as compared to the linear kernel. Other types of kernels
I used were the profile and quadratic kernels, however the best results were
achieved using the linear and mismatch kernels.
Weighting
As described in Chapter 2, I weighted residues to the left and to the right of
target lysines within the sequence alignment. The weight was added to the
raw alignment score such that the Ts= Raw alignment score + ∑wi of each
identical or evolutionarily similar flanking residue, where Ts = total score,
and wi = 1/d; d= position of flanking residue with respect to lysine. I also
grouped chemically similar residues together, such that residues that may
not be evolutionarily similar according to the BLOSUM matrix, but within the
same chemical group, such as small, aromatic, hydrophobic, etc. are also
given weight to. Using chemical similarity improved the algorithm
performance by a five to eight percent margin (accuracy measure) for both
histones and non-histone proteins, and thus I included chemical similarity in
my optimal tree analysis.
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Sequence logos
Sequence logos for displaying the flanking residue distribution of all lysines
in my training and test datasets were created according to (Crooks, Hon et
al. 2004).
Software URL
The acetylation prediction software, PredMod can be found at
http://www.cs.cornell.edu/w8/~amrita/predmod.html
Cross Validation and Evaluation of Test Sets
I used Leave One out cross Validation (LOV) of histone lysines on the
training set and performed a ROC analysis. The predictive performance was
monitored using the AUC metric (Dodd and Pepe 2003) on the test lysines. I
applied the procedure to 1000 random permutations of the labels of the
observed and not observed lysines. The independent datasets were also
measured by a ROC analysis, as described previously.
Human Nonhistone Analysis Method
In order to measure whether the prediction method also works on
nonhistone lysines, I first applied my algorithm to a list of validated lysine
acetylation sites in human nonhistone proteins. I used the following two
independent validation datasets for my analysis: Firstly, a proteomics
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survey of published cytosolic and nuclear protein fractions from Hela cells
that were subjected to immunoaffinity purification using a pan-acetyl lysine
antibody was applied. Isolated peptides were analyzed by HPLC-MS/MS and
the final output contained 51 acetylated lysines in 38 proteins (Kim, Sprung
et al. 2006). Secondly, I screened the literature for acetylated proteins and
found 32 molecules containing 73 acetylated lysines that were reported as
acetylated both in vitro and/or in vivo using mass spectrometry and
immunoblotting detection methods. The test data sets were composed of
lysines that were identified as acetylated and represent my positive set
(“validated”), and lysines that were not observed as acetylated within these
investigated substrates represented my negative dataset (“not observed”).
By comparing validated acetyl marks to my computationally predicted
acetylation marks, we tested whether sites are dictated by the surrounding
amino acid sequences to validate my stated assumption that there is an
intrinsic substrate specificity for KATs true for both histone and nonhistone
proteins.
Acetylation (Experimental)
Cell Lines
Mammalian cell lines were grown in Iscove's DMEM supplemented with 10%
fetal calf serum and penicillin/streptomycin at 37°C and 5% CO2.
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Human Histone Purification
Cell nuclei were isolated by hypotonic lysis in buffer containing 10 mM TrisHCl (pH 8.0), 1 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 0.4 mM PMSF, and
protease and phosphatase inhibitors. Pelleted nuclei were extracted using
0.4 M sulfuric acid. The acid-soluble histones were precipitated with
trichloroacetic acid and resuspended in water. Histones were separated by
reverse phase HPLC using a C8 column (220 by 4.6 mm Aquapore RP-300,
PerkinElmer Life Sciences) with a linear ascending gradient of 35–60%
solvent B (solvent A: 5% acetonitrile, 0.1% trifluoroacetic acid, solvent B:
90% acetonitrile) over 75 min at 1.0 ml/min on a Beckman Coulter System
Gold 126 Pump Module and 166/168 Detector. For the additional data that
was obtained from sodium butyrate treated samples, histones were purified
from HeLa S3 cells and treated with 10mM sodium butyrate for 15 hmys
prior to harvesting (STable 6). H3 was also purified from HEK293 cells
treated with sodium butyrate (see below).
Mass Spectrometric Analysis of Human Histones H2A and H3
Histones were isolated and H2A was purified as described previously
(Shechter, Dormann et al. 2007) from HL60 cells. The HPLC fraction
containing purified H2A was resuspended in water, and an aliquot was
diluted with 100 mM ammonium bicarbonate, pH 8. The diluted aliquot was
divided in half. One half was digested with GluC protease (Princeton
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Separations, Inc, Adelphia, NJ) at a substrate-to-enzyme ratio of 20:1 for 4
h at RT, and glacial acetic acid was used to quench the digest. An aliquot of
the GluC-digested H2A containing approximately 1 picomole of H2A was
diluted 3-fold with ammonium bicarbonate to increase the pH to 8.0. H2A
peptides were then derivatized by treatment with deutero succinimido
acetate. This reagent was created by adding deutero acetic anhydride and
triethylamine to N-Hydroxysuccinimide, and the white precipitate was
collected after rinsing with hexanes. 0.35mg (≈ 2 micromoles) of deutero
succinimido acetate was added to the H2A peptide mixture, containing an
estimated 20 picomoles of free amino groups. The deutero-acetylation
reagent and H2A peptides were allowed to react for 2 h at 4 °C. Deuteroacetylation of the N-termini of peptides and the epsilon amino groups of
lysine residues increases the hydrophobicity of the H2A peptides, and allows
the smaller, hydrophilic peptides of H2A to be retained on a C18 column.
Instead of adding a 42-Da acetyl group (C2H3O), this reagent adds a 45-Da
acetyl group (C2D3O) since it contains 3 deuteriums instead of 3 hydrogens.
Therefore, an in vivo lysine acetylation is distinguished from a deuteroacetylation because of their difference in mass.
After performing this reaction, the mixture was acidified with glacial acetic
acid and loaded onto a capillary precolumn (360 μm O.D. x 75 μm I.D. fused
silica, Polymicro Technologies, Phoenix, AZ) packed with irregular 5–20 μm
C18 resin (YMC Inc., Wilmington, NC). The precolumn was then connected to
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an analytical column packed with regular 5 μm C18 resin equipped with an
electrospray tip.H2A peptides were separated using nanoflow HPLC on an
1100 series binary HPLC pump (Agilent Technologies, Palo Alto, CA) coupled
to a micro-electrospray ionization smyce on a Finnigan LTQ Orbitrap mass
spectrometer (Thermo Scientific, San Jose, CA) The HPLC gradient consisted
of 0-60 %B in 50 min and 60-100 %B in 10 min (solvent A: 0.1 M acetic
acid, solvent B: 70 % acetonitrile, 0.1 M acetic acid), with a flow rate of 60
nL/min. Full mass spectra were acquired with the Orbitrap as the analyzer,
and MS/MS spectra were acquired in the LTQ ion trap. After each full MS
scan, m/z values of 535.6, 537.1, 513.1, 514.6, 534.1, and 511.6 were
targeted sequentially for isolation and fragmentation. The last scan event in
the cycle (prior to acquisition of the next full MS scan) was a data-dependent
MS/MS scan of the most abundant ion in the previously acquired full MS
scan. MS/MS spectra were manually interpreted. This approach employing
GluC digestion and deutero-acetylation was used to examine the C-terminal
H2A peptide, residues 122-129.
The second half of the H2A aliquot was treated with propionic anhydride to
derivatize endogenously monomethylated and unmodified epsilon amino
groups of lysine residues. Chemical derivatization with propionic anhydride
converts amino groups of lysines to their corresponding propionyl amides
and has been detailed previously (Garcia, Mollah et al. 2007). Briefly, equal
volumes of propionylation reagent and protein were reacted, and
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derivatization was repeated twice to ensure full conversion of amino groups.
The sample was vacuum-dried after each derivatization. H2A was then
digested with trypsin (Promega, Madison, WI) at a substrate-to-enzyme
ratio of 20:1 for 7 h at 37 °C. Derivatization blocks lysine residues from
cleavage, and thus trypsin cleaves C-terminal to arginine residues only. The
resulting H2A peptide mixture was acidified with glacial acetic acid and
loaded onto a reverse phase capillary column for LC-MS/MS analysis as
described above. H2A peptides were analyzed using a hybrid quadrupole
linear ion trap Fourier transform (LTQ-FT) mass spectrometer (Thermo
Scientific, San Jose, CA). The LTQ-FT instrument was operated in datadependent mode with dynamic exclusion enabled. The data-dependent
method consisted of acquisition of a full scan mass spectrum using the FT as
analyzer followed by ten MS/MS scans of the ten most abundant ions in the
initial full scan. MS/MS scans were acquired using the ion trap as the
analyzer and spectra manually interpreted. This approach employing
propionylation and trypsin digestion was used to examine N-terminal H2A
peptides, 4-11 and 12-17.
Histone H3 was purified as described previously (Garcia, Barber et al.
2005; Hake, Garcia et al. 2006) from sodium butyrate-treated HEK293 cells.
H3 was treated with propionic anhydride and digested with trypsin, similar to
the procedure described for H2A. Following digestion, the samples were
again reacted with propionic anhydride to derivatize the amino-termini of the
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trypsin-generated H3 peptides. The peptide mixture was dried in a speedvac concentrator, and subsequently reconstituted in 0.1% acetic acid. H3
peptides were loaded onto a capillary reverse phase precolumn, and the
precolumn was connected to an analytical column as described above.
Peptides were gradient-eluted into an LTQ Orbitrap mass spectrometer
(Thermo Fisher Scientific, San Jose, CA). The instrument was operated in
data dependent mode and cycled through acquisition of a full mass scan
followed by MS/MS scans of the ten most abundant peptide cations in the
initial full scan. This approach was used to examine the N-terminal H3
peptide, 27-40. All MS/MS spectra were manually interpreted.
Mass spectrometric analysis of nonhistone lysine acetylation sites
Tagged cells of my nonhistone proteins were lysed under cryogenic
conditions. Tandem Tap-tag purification was performed on candidate yeast
proteins as described (Puig, Caspary et al. 2001) and eluates run on SDSPAGE gels and stained with coomassie. Protein bands were in-gel digested
with trypsin or chymotrypsin, and peptides extracted.
Each of the protein bands were cut into two pieces with similar size and
washed with 10% acidic acid in 50% ethanol (acetic acid:ethanol:water =
10:50:40 (v/v/v)) three times and then overnight. After destaining three
times with 25 mM ammonium bicarbonate in ethanol buffer (ethanol:water =
50:50 (v/v)), the gel bands were swollen in water twice and then cut into
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small pieces. They were dehydrated in acetonitrile and then dried in a
SpeedVac (Thermo electron, Waltham, MA). Overnight digestion was
performed at 37 ºC with about 200 ng of modified porcine trypsin (Promega,
Madison, WI) or chymotrypsin (Roche, Indianapolis, IN) in 50 mM
ammonium bicarbonate. The resulting peptides were extracted sequentially
with 5% TFA/50% acetonitrile/45% water (v/v/v), and 0.1% TFA/75%
acetonitrile/24.9% water (v/v/v), and 100% acetonitrile. The extracts were
combined and dried in a SpeedVac. The resulting peptides were cleaned with
C18 ZipTips (Millipore, Bedford, MA) according to the manufacturer’s
instructions, prior to nano-HPLC/mass spectrometric analysis.
The extracted peptides were separated using a capillary HPLC column (11
mm length × 75 μm I.D., 4 μm particle size, 90 Å pore diameter) packed inhouse with Jupiter C12 resin (Phenomenex, Torrance, CA). LC-MS/MS
analysis was performed in an integrated system that includes an Agilent
1100 series nanoflow LC system (Agilent, Palo Alto, CA) and a LTQ 2D trap
mass spectrometer (Thermo Electron, Waltham, MA) equipped with a
nanoelectrospray ionization (NSI) smyce. The gradient-eluted peptides
were electrosprayed directly into the LTQ mass spectrometer, which was
operated in a data-dependent mode. Mascot (version 2.1, Matrix Science,
London, U.K.) was used for database searching. Acetylated lysine containing
peptides identified with a Mascot score of 20 or above were manually
verified by a method described previously (Chen, Kwon et al. 2005).
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Yeast Strains and Plasmids.
Strain MSY421 from M. M. Smith (University of Virginia) [MAT a, Δ(hht1hhf1) Δ(hht2-hhf2) leu2-3, 112, ura3-62, trp1, his3, pMS329 (HHT1-HHF1,
URA3, CEN)] was used to shuffle in plasmids containing histone H3 A15K,
H3G13V, and H3A15V mutations using 5-FOA as a counterselecting agent for
the URA3 plasmid. The mutant plasmids were generated by PCR
mutagenesis (H3A15K, H3A15V, H3G13V) and confirmed by sequencing. The
final yeast strain was confirmed by PCR amplification of the HHT2-HHF2
locus and DNA sequencing. Yeast growth, plasmid and DNA fragment
transformation of yeast cells were done according to standard yeast
protocols (Hieter et al, Methods in Yeast Genetics).
Extraction of Histones
Histones were extracted from nuclei made from 1 liter of cells grown to an
OD600 of 0.8 in yeast-rich media. Nuclei were prepared in the presence of
protease inhibitors, and histones were obtained by acid extraction as
described in (Hsu, Sun et al. 2000). One-tenth of each fraction was used to
confirm the presence of purified histones by SDS/PAGE separation and
Coomassie blue staining. The remainder of the fraction was used for MS
analysis.
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Mass Spectrometry of Yeast Histones
Histones were prepared using propionic anhydride reagent and digested with
trypsin as described previously (Garcia, Mollah et al. 2007). For mass
spectrometry analysis, histones were loaded on to C18 packed columns and
separated using an Agilent 1200 series HPLC system (Agilent Technologies),
and the LC gradient used was 5% B to 45% B over 60 min. All data was
acquired on an LTQ-Orbitrap as previously described (Leroy, Toubeau et al.
2006).
Domain Prediction (computational)
I performed the domain prediction analysis by creating a multiple sequence
alignment of known effector proteins of my domain of interest using the
software program ClustalW. Sequences that were fed into my MSA were
based on a concatenated sequence, ie. If the domain consisted of a helix,
loop, helix, then I ensured that the loop region of the sequence had a lower
gap penalty, while the helix part of the sequence had a more stringent gap
penalty (JPred) (Cole, Barber et al. 2008). The MSA was then fed into a
Hidden Markov Model 2.0 which calculated the probability of the output
sequence based on a probabilistic weight analysis of input sequences. The
final result I obtained was an E-value of the statistical significance of my
prediction given the selected parameters. I compared this value against an
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unadjusted loop, and so I obtained a list of predictions for the unadjusted
and adjusted loops.
PcG domain detection
I selected E(z), Pc, dRing and Psc as my PcG reference set: the “writer”
(E(z)) and the “reader” (Pc) of the H3K27me mark, the only other known
catalytic member of the PcG (dRing), and dRing’s associated factor (Psc).
Sequence and domain information was retrieved for Drosophila, mouse, and
human PcG proteins from the Swissprot, Uniprot, Ensembl, and SMART
databases. In order to identify putative homologs of these proteins in other
organisms, I performed BLAST searches using the Drosophila, mouse and
human proteins as queries2, 3. The Blastp searches, using the NCBI web
server (http://www.ncbi.nlm.nih.gov/BLAST) were performed at low,
medium, and high stringencies to obtain all possible proteins in the following
organisms: Arabidopsis thaliana, Caenorhabditis elegans (worm),
Strongylocentrotus purpuratus (sea urchin), Danio rerio (zebrafish), Xenopus
laevis (frog), Gallus Gallus (chicken), Canis familiaris (dog), Mus musculus
(mouse), and Homo sapiens (human). Since homologous domains between
my species are very well conserved, variation of BLAST parameters, such
as gap costs and substitution matrices did not significantly alter my results.
In addition, I developed a program (Motif Search) to query motifs less than
15 amino acids in length such as the Pc box. Sequence similarity between
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homologous domains and full-length sequences was used to compute a
weighted score by multiplying a fixed weight to the BLAST score and
computing an overall weighted sum. Key domains for PcG proteins were
identified including: the chromodomain and Pc-box for Pc homologs, the
RING domain for Psc and dRing homologs, and the SET and SANT domains
for E(z) homologs. A list of putative homologs containing the highest scores
was compiled for each class of PcG proteins, and homologs in different
species were selected by manual inspection. Finally, the ClustalW
program was used to cluster putative homologs to ensure that proteins with
similar key domains with minor amino acid differences such as Ring1A and
Ring1B were categorized correctly. In addition, a reverse BLAST of all the
putative homologs was also performed against the Drosophila genome to
ensure that the forward BLAST hit was accurate. Many databases of
translated cDNA libraries are inherently incomplete, and so gene sequences
of those PcG homologs that were found to be absent in a given organism
were also queried against the organism’s genome. Finally, putative PcG
homologs were mapped onto a phylogenetic tree of organisms. Additional
potential paralogs of dPsc were found in Drosophila through my algorithm.
These proteins are Su(z)2 and l(3)-73Ah; however as they are not well
characterized as functional Psc homologs, these proteins have been excluded
these proteins from my phylogenetic tree.
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Sequence alignments were constructed using the Emboss program and
CEC-1 was predicted as a putative Polycomb homolog because of its high
sequence similarity with Drosophila and mouse Cbx8 chromodomains. Two
stretches of amino acids within the N-terminus and C-terminus of CEC-1 also
shared a strong sequence similarity with the Drosophila and mouse Cbx8 Pc
boxes. In Figure 4.5B, the ClustalW program was used to create a multiple
sequence alignment of Cbx proteins and subsequently fed into the PHYLIP
software program5. The protdist and neighbor joining programs within
PHYLIP were used to construct the Cbx paralog tree (Figure 4.5B) and the
Emboss local alignment program was used to determine sequence similarity
and identity percentages.
Domain Prediction (Experimental)
Peptide Pulldown Assay
Extracts were made by taking frozen, lysed cells (1 g/ pull-down condition)
and extracting them in 500cmM extraction buffer (500 mM NaCl, 20 mM
HEPES pH 7.9, 25% glycerol, 1.5 mMcMgCl2, 0.2 mM EDTA, 1 mM PMSF,
Complete Mini EDTA-free [Roche], 0.2% Triton X-100) for 1 hour at 4°C.
Extracts were then diluted to 150 mM NaCl with ‘no-salt’ extraction buffer,
mixed with 2.5 μg of biotinylated histone peptide-linked Dynabeadsc(M-280
Streptavidin, Dynal) at the ratio of 2.5 μg /100 μL beads and nutated for 30
minutes at 4°C. Peptide-linked Dynabeads and associated proteins were
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then washed five times in 300 mM KCl wash buffer (300 mM KCl, 20 mM
HEPES pH 7.9, 0.2% Triton X-100), and one time in a buffer containing 4
mM Hepes pH 7.5 and10 mM NaCl. Peptide-bound proteins were eluted in
boiling SDS-PAGE loading buffer, resolved on Novex 4-20% gradient gels,
and probed with antibodies recognizing the PrA tag (DAKOP0450). Peptides
were synthesized by Upstate Biotech (UBI) and Proteomics Resource Center
of The Rockefeller University.
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Appendix

Collaborations

During my PhD, I had a chance to collaborate with a variety of groups on
and off the Rockefeller campus. A group that I collaborated with was Dr.
Dmitri Krainc’s group, at Harvard Medical School (Cambridge, MA). His group
was interested in looking at human Htt (a Hungtingtin disease related
protein), and was interested in studying PTMs on this specific protein. I
contributed to this project by using my software tool, PredMod, to predict
several acetylation sites on this protein. My top ranked predicted lysine was
K444,

which

eventually

was

shown

to

facilitate

trafficking

into

autophagosomes, and had an effect on neurodegeneration in cultured
neurons and in mouse brain (Jeong, Then et al. 2009).
A second collaboration that I was involved in with the lab of Dr. Elliott
Hertzberg at Albert Einstein College of Medicine, who was involved in looking
at a series of Connexin proteins (gap junction proteins) in rat cells. My top
predictions aligned with their primary detected acetyl-sites in Connexin23.
They are in now the process of conducting further experiments to determine
the acetyltransferase of the lysine mark.
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Software Tools
During my graduate studies, I developed PredMod as described in the
computational section of my thesis. The usage of this tool is as follows:
Usage of PredMod. After you have inserted the sequence of your protein of
interest, press “Submit” and the following output will appear: The first
section displays the entire sequence with each lysine colored red or blue. A
red colored lysine indicates that the lysine is predicted as acetylated, and a
blue colored lysine suggests that the lysine is not acetylated. Listed below
the protein sequence are the total number of predicted acetylated lysines,
not predicted as acetylated lysines, and a total lysine count. In the second
section, you will see that there are two tables of proteins, one table shaded
in yellow and one table shaded in blue.

Table columns are as follows:

Position of lysine in protein, confidence (calculation described below), and
the flanking sequence with the target lysine bolded. The yellow shaded list
contains predicted acetylated lysines, and the blue shaded list lysines that
are not predicted as acetylated. Note that the confidences are in ranked
order. The top-most yellow shaded lysine is the lysine predicted as
acetylated with the highest confidence. The bottom-most blue shaded lysine
is least likely to be acetylated.

Note that this program runs at a lower

stringency threshold than results reported in the text (high stringency), and
thus the output contains a higher number of positive predictions.
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Confidence levels are calculated by the difference between the output score
and the optimal calculated threshold. Thus, if a lysine scores above the
designated threshold, it is predicted as an acetylated lysine. Confidence
values range between 0.5 and 67, where 67 most likely represents an
identical match between a histone sequence existing in the training set and
an identical input sequence.
Another tool, useful for the lab was Motif Search, a software program which
enables a user to enter any length motif, and then this motif is searched for
in the entire proteome of all organisms. The output received is something
like this:
Together, PredMod along with Motif Search can potentially help the scientific
community obtain additional information on their “favorite protein.”
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All Tables

Table represents lysines in human histones H3, H4, H2B, H2A and their acetylation status as
noted in literature (references are in rightmost column). Asterisk (*) represents lysines that
were predicted by the algorithm and validated experimentally by mass spectrometry.
Human Histone H3.1 (NP_003520.1)
Lysine residue
K4

Validated
Acetylated
X

K9

X

K14

X

K18

X

K23

X

K27

X

as

Not Observed as
Acetylated

Reference(s)
(Zhang, Tang et
al. 2002; Zhang
and Tang 2003;
Zhang, Eugeni et
al. 2003; Garcia,
Barber et al.
2005; Hake,
Garcia et al. 2006;
Garcia, Hake et al.
2007)
(Cocklin and Wang
2003; Beck,
Nielsen et al.
2006)
(Cocklin and Wang
2003; Beck,
Nielsen et al.
2006; Kim,
Sprung et al.
2006)
(Garcia, Hake et
al. 2007),(Hake,
Garcia et al.
2006),(Zhang and
Tang 2003),(Beck,
Nielsen et al.
2006),(Kim,
Sprung et al.
2006)
(Garcia, Hake et
al. 2007),(Hake,
Garcia et al.
2006),(Zhang and
Tang 2003),(Beck,
Nielsen et al.
2006),(Kim,
Sprung et al.
2006)
(Cocklin and Wang
2003; Beck,
Nielsen et al.
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K36

X

K37
K56

X

K79

X

2006)
(Morris, Rao et al.
2007)
*(sod but)
(Xie, Song et al.
2009),(Das, Lucia
et al. 2009)
(Garcia, Hake
al. 2007)

K64
K115
K122

X
X
X

Human Histone H4 (NP_003529.1)
Lysine residue
K5

Validated
Acetylated
X

K8

X

K12

X

K16

X

as

Not Observed as
Acetylated

References
(Zhang,
Williams et
al. 2002;
Smith,
Gafken et
al. 2003;
Pesavento,
Kim et al.
2004)
(Zhang,
Williams et
al. 2002;
Smith,
Gafken et
al. 2003;
Pesavento,
Kim et al.
2004)
(Zhang,
Williams et
al. 2002;
Smith,
Gafken et
al. 2003;
Pesavento,
Kim et al.
2004)
(Zhang,
Williams et
al. 2002;
Smith,
Gafken et
al. 2003;
Pesavento,
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et

Kim et al.
2004)
K20
K31
K44
K59
K77
K79
K91

X
X

(1)
X
X
X
X
X

Human Histone H2B.2(Q) (NP_003519.1)
Lysine residue
K5

Validated
Acetylated
X

K11

X

K12

X

K15

X

K16

X

K20

X

K23

X

K24
K37
K30
K34
K43
K46
K57
K85
K108
K116
K120
K125

X

as

Not Observed as
Acetylated

References
(Beck, Nielsen et
al. 2006),(Kim,
Sprung et al.
2006)
(Beck, Nielsen et
al. 2006),(Kim,
Sprung et al.
2006)
(Bonenfant, Coulot
et al. 2006)
(Bonenfant, Coulot
et al. 2006)
(Beck, Nielsen et
al. 2006),(Kim,
Sprung et al.
2006)
(Beck, Nielsen et
al. 2006),(Kim,
Sprung et al.
2006),(Bonenfant,
Coulot et al. 2006)
(Kim,
Sprung et
al. 2006)
(9)

X
X
X
X
X
X
X
X
*(sod but)
X
X
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Human Histone H2A.C (NP_003503.1)
Lysine residue
K5

Validated
Acetylated
X

as

Not observed as
Acetylated

References
(Bonenfant, Coulot
et al. 2006)
*
*
*

K9
K13
K15
K36
K75
K76
K95 (R)
K118
K119
K125 (R)
K127(R)
K129

X
X
X
X
X
X
*
*
*

Note (R) stands for reversed sequences that were used in the alignment
H2AK125
KTESHHKAKGK
(R)KGKAKHHSETK
H2AK125
ESHHKAKGK
(R)KGKAKHHSE
H2AK96
NDEELNKLLGRVT
(R)TVRGLLLKNLEEDN
(sod but) =This modification observed under sodium butyrate treatment
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Human pan-acetyl IP substrates

Table includes published proteins that were immunoprecipitated with a pan-acetyl antibody
(Kim, Sprung et al. 2006). Asterisk (*) represents lysines that were not predicted by the
algorithm but experimentally identified by mass spectrometry.

*

Predicted/valid
ated
(position
on
protein)

Predicted but
not
validated
experimentally
by algorithm
(position
on
protein)
at
threshold
7,10,159

18

350

144,145,52

1570

121

1531,1533, 1535

P29ING4 (gi|18873723)
CREB binding (peptide
info only known)
DNMTl (gi:62088406)

249

28

130
6

999, 1003 , 472,
1366, 984
129, 156, 160

127*

1601

137

SON
DNA
BASS1
(gi|5737751)
HMG1 (gi|96888)
MYST3 (gi|150378493)

344

26

1100,
1098,
1102,1104
206

135,1589,160,9
44
144, 157, 98

117*

215
2004

43
139

7,8,114,177
1165,
365,1014,1154

28*
815*

462
639
724

47
39
75

318*
109*

624

385, 386
605, 617, 604
148, 505

205

6

123

171, 198, 112

539

40

20

165

14

125

509, 364, 528
44,49,76

166
140
232

25

132

164,31

22

363

19

Protein/accession
number

Total
residu
es

Lysines

Set-translocation
(gi:4506891)
HrNP
(gi:14043070)
SMARCA (gi|55958983)

277

18

372

MLL3(insufficient
support
for
the
transcript
and
the
protein)
EF1alpha (gi|62896589)
PHD15 (gi|18676594)
Heat
shock
90kd
Protein 1 Beta
(gi|34304590)
Heat
shock
27
KD
(gi|4504517)
Chaperonin
(gi|1137641)
Peptidyl-prolyl
isomerase(cyclophilin)
(gi|10863927)
Cofilin(gi|30582531)
Profilin1 (gi|30582841)
Tropomyosin3(gi|55665
780)
Actin (gi|16924319)

100
49

180

105*
212*

LMNA (gi|21619981)
ANXA5(gi|12655149)
RHO
gdi
alpha
(gi|30582607)
Phospholipase Cbeta 1
(gi|9438229)
Phosphoglycerate
mutase 1
PEST (gi|9966827)
Cyclin T1 (gi|2981196)
VegF (gi|3712671)
B23
nucleoplasmin
(gi|825671)
Thierodoxin
(gi|55957946)
BCell (gi|32698936)
GAPD(gi|230868)

465
320
204

32
22
19

1210

120

254

18

179
726
254
280

22
51
21
66

85

11

1494
334

41
26

36

LOC84081
(gi|62020992)
HYPK (gi|27692116)
Rbbp7 (gi|57209887)

557

70

499

410, 413, 56

129
285

9
16

35

87
79, 9, 21

39*

180
457

10
33

48
66

94, 78

54*
431*

108
2414

7
108

13, 42
1555 ,1554

28
1549,1550

UBL4A (gi|57284174)
Transkeletose
(gi|31417921)
Aldolase A (gi|28595)
P300(gi|50345997)

418
101
141

316, 90, 180
29, 26 , 212

966, 1070, 1079

971*

106

39

171, 169
198

93,219, 356
174, 44
40,188

152*
492*
176*
136*

65

74*

49,275, 234
2,112,116,65

60*
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1560
*,
1558
*

Literature validated human proteins.

Table includes lysines that were reported as acetylated in literature. Asterisk (*) represents
lysines that were not predicted by the algorithm but identified experimentally by MS.
Protein/accession
number

Total
residu
es

Lysin
es

Predicted/vali
dated
(position
on
protein)

TFIIB (gi|135629)
P53(gi|23491729)

290
393

31
19

238
320, 370
321,305

Rch1 (gi:791185)
Myc (gi:71774083)

529
439

28
24

Smad 7 (gi|18418630)
Stat1 (gi|2507413)

426
749

20
55

22
317, 143, 157,
371, 275, 323
64,70

HIV1 – integrase
http://ca.expasy.org/unipro
t/A6YEJ0

288

26

266,273

219, 71

MyoD (gi|34862)

319

11

102

133

HIV-tat (gi:114842145)
Alpha-Tubulin (gi|55977864
)
ACTR (gi:2707770)

101
451

13
19

53, 12
60, 338, 112

1412

55

691, 316 , 87

HMG14(Chen, Lin
1999) (gi:184251)
CDK9 (gi|8099630)
P65 (gi|5689767)

216

43

11 , 2

8, 87 , 172

372
551

29
17

44

24, 272, 178
123, 343

HMG-A1 (gi|123377|)
Stat3 ( gi|48429227)
ANDR (gi|113830)
Esr1 (gi|544257)

107
770
919

16
47
39

65, 67,71
685
630,632,633

55, 15
631, 548, 153
299,316, 590

595

28

299

401,266

Gata3 (gi|120962)

443

21

302

P73 (gi:2370177)

500

17

331, 321

RB (gi|132164| )

928

76

250,
159,
254
346,
138,
157, 192
417,
432,

et

al.

182

Predicted
but
not
validated
experimenta
lly by our
algorithm
(position on
protein)
at
threshold
267, 136, 14
357, 139, 120

*

52*
372*,
386*,
373*,
382*

102, 42
422,289,355
5,185
679, 511

410*,
413*
264*

99*,
104*
50*
40*
630*,
629*

48*
221*

302*,
303*
305*
327*
873*,

265,8
270,672
297, 159, 629
241, 11, 518,
129
272, 354, 179

874*
345*
532*

21
80
59

180, 182, 243
277, 513, 276
253,249,358

798

47

646,
656,
194, 254

399*
294*
539*,
542*
278*,
271*,1
46*

HTT (gi|1170192)

3144

278

RIP140(gi|57232746)

1158

92

CDT1(gi|224471822)

546

23

Beta catenin (gi|860988)
HIF-1 (gi|4504385)
SATB1 (gi|417747)

781
826
763

26
49
44

49
136

FOX01
(gi|116241368)
INAR2 (gi|1352466)
HSP90alpha (gi|92090606)
Ku70 (gi|125729)

655

25

245, 248, 265

515
732
609

PGRC1
(gi|6647589)

444

49

183

178,1168,92,
410,700
724,
249,1105,
127, 97

429,218, 166,
100

111*,
158*,
286*,
310*,
481*,
446*
24*

Literature validated
acetylation sites.

human

proteins

and

Protein
TFIIB
HMG-A1
P53
Gata1
Rch1
HMG-14
C-Myb

References
(Imhof, Yang et al. 1997)
(Munshi, Merika et al. 1998)
(Gu and Roeder 1997)
(Boyes, Byfield et al. 1998)
(Bannister, Miska et al. 2000)
(Bergel, Herrera et al. 2000)
(Tomita, Towatari et al. 2000)

E2F1

(Martinez-Balbas, Bauer et al. 2000)

C-myc

(Zhang, Faiola et al. 2005)

Smad7

(Simonsson, Heldin et al. 2005)

Stat1
HIV1-integrase
MyoD
HIV-tat

(Kramer, Baus et al. 2006)
(Kiernan, Vanhulle et al. 1999)
(Polesskaya, Duquet et al. 2000)
(Dormeyer, Dorr et al. 2003)

ACTR

(Chen, Lin et al. 1999)

CDK9

(Fu, Yoon et al. 2007)

P65

(Ishinaga, Jono et al. 2007)

SATB1

(Pavan Kumar, Purbey et al. 2006)

STAT3

(Glozak, Sengupta et al. 2005)

HMGB-1

(Glozak, Sengupta et al. 2005)

Beta-catenin
Alpha-tubulin

(Wolf, Rodova et al. 2002; Levy, Wei
et al. 2004)
(Glozak, Sengupta et al. 2005)

GATA3

(33)

P73

(33)

SMC3

(Zhang, Shi et al. 2008)

HIF-1

(Jeong, Bae et al. 2002)

RB

(Markham, Munro et al. 2006)

ESR1

(Fu, Wang et al. 2004)

Ku70

(35)

Hsp90

(35)
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the

references

of

Fox01

(Greer and Brunet 2005)

PGC1

(35)

INF

(35)

AR

(Fu, Wang et al. 2004)

HTT
CDT1
RIP140

(Jeong, Then et al. 2009)
(Glozak and Seto 2009)
(Yang and Seto 2008)
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P-values in Chapter 2
To test whether the observed enrichment of small residues (G/A), K, S was
statistically significant in the histone and nonhistone datasets, I determined
the frequency of these same residues flanking a lysine in the entire human
proteome. I employed the hypergeometric test to measure the statistical
relevance of this observation (STable 4). “LIT” represents those lysines
validated in literature, “HIST” represents lysines in histones, and “PAN”
represents pan-acetyl antibody substrate lysines. Top row shows the
position of the residue with respect to the target lysine (position 0, not
shown). List below the table displays the values for each of the variables in
the hypergeometric distribution: all lysines in the human proteome = N;
number of times the particular residue is seen flanking in each position in
human proteome= K; total number of lysines in each independent
validation dataset = n; number of times particular residue is seen flanking
in each position in validation dataset = m.

small
LIT
HIST
PAN

K
LIT
HIST
PAN

S
LIT
HIST
PAN

-6

-5

-4

-3

-2

-1

1

2

3

4

5

6

0.0
04
0.0
1
0.0
5

1

0.9

2e-1

9e-4

7e-6

0.5

1e2
0.8
5

2e-1

0.44

9.2e4
0.03

3e-1

1

1.9e8
0.09

0.3
2
2e3
0.1
8

0.47

0.7

0.00
4
2e5
0.00
4

0.4

0.01

0.00
3
1.6e5
8.6e5

0.17

5.91e
-4

1e3
0.7

0.0
6
0.3
3
7.3
e-9

0.7

0.03

0.13

0.36

0.6

0.01

0.3

0.3

0.1

0.2

0.02

1.86e
-4
0.2

0.7

0.5

0.47

0.4

0.5

0.0
2
0.4

0.3

0.08

0.6

0.00
99

0.11

0.07

0.7

0.0
1

0.3

0.16

0.007

0.02

0.3
9
0.4
5
0.2

0.12

0.005

0.05

0.12

0.09

0.99

0.8

0.3

0.5

0.8

0.5

0.2

0.8

0.8

1

0.01

0.9

0.1
5
0.3

0.8

0.5

0.46

0.4

0.04

0.11

0.11

0.6

0.09

0.8

0.0
7

0.15

0.2

0.2

5.6e4
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N in human dataset = 5127294
K in each position for small, serine, and lysine residues dataset
containing all human lysines.
Position
Position
Position
Position
Position
Position
Position
Position
Position
Position
Position
Position

0: GA:535591 S:291208 K:389280
1: GA:621026 S:315489 K:323314
2: GA:677578 S:307757 K:416567
3: GA:663899 S:312774 K:468003
4: GA:632418 S:310841 K:537247
5: GA:584283 S:289536 K:486015
7: GA:597697 S:296377 K:486758
8: GA:610849 S:404638 K:537885
9: GA:593694 S:362154 K:462707
10: GA:586526 S:336826 K:418813
11: GA:591499 S:303442 K:325808
12: GA:531503 S:292427 K:387452

m in each position for small, serine, and lysine residues: Human
Histone Dataset
Position 0: GA:7 S:2 K:3
Position 1: GA:8 S:2 K:5
Position 2: GA:3 S:3 K:9
Position 3: GA:16 S:1 K:2
Position 4: GA:10 S:1 K:3
Position 5: GA:12 S:0 K:3
Position 7: GA:12 S:5 K:3
Position 8: GA:8 S:1 K:3
Position 9: GA:9 S:3 K:3
Position 10: GA:4 S:1 K:13
Position 11: GA:5 S:2 K:4
Position 12: GA:9 S:2 K:2
m in each position for small, serine, and lysine residues: Pan-acetyl
(PA) Dataset
Position 0: GA:10 S:5 K:12
Position 1: GA:11 S:4 K:11
Position 2: GA:8 S:7 K:6
Position 3: GA:11 S:6 K:11
Position 4: GA:12 S:3 K:9
Position 5: GA:17 S:6 K:9
Position 7: GA:11 S:6 K:4
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Position
Position
Position
Position
Position

8: GA:5 S:3 K:12
9: GA:9 S:7 K:6
10: GA:9 S:6 K:7
11: GA:11 S:5 K:9
12: GA:5 S:5 K:9

m in each position for small, serine, and lysine residues: Literature
(Lit) Dataset
Position 0: GA:13 S:4 K:8
Position 1: GA:7 S:6 K:3
Position 2: GA:4 S:9 K:9
Position 3: GA:9 S:7 K:8
Position 4: GA:16 S:6 K:7
Position 5: GA:14 S:6 K:5
Position 6: GA:0 S:0 K:57
Position 7: GA:8 S:2 K:11
Position 8: GA:8 S:7 K:7
Position 9: GA:8 S:5 K:10
Position 10: GA:7 S:4 K:6
Position 11: GA:14 S:2 K:6
Position 12: GA:6 S:13 K:6
n(hist) = 21 ; n(lit) = 49 n(pan) = 67
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S. cerevisiae chromatin-associated protein predictions
yEAF7
Predictions: K27, K343, K165, K142
ySPT6
Predictions: K958, K491, K494, K118, K120, K319
ySir3
Predictions: K52, K436, K445,K3,K827

Sodium butyrate (10mM) treated samples
Additional acetylation sites detected:
H2A: K95, K119
H2B: K34, K46, K108, K116
H4: K77, K79, K91
H3:K37
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Appendix Figures
Appendix Figure 1: Enlarged tree from Figure 2.3.
Legend same as in 2.3.
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Appendix Figure 2. Experimental Mass Spectrometry validation in human cells
A. CAD (Collisionally Activated Dissociation) mass spectrum of the [M+2H]2+ histone H2A 4-11
peptide. Shown is a mixture of two single-acetylated species with the same sequence but with
different sites of acetylation. The MS/MS data indicate acetylation on K5 and K9. The amino acid
sequence is shown above the spectrum, and the masses associated with the sequence
correspond to the expected b- and y-type fragment ions for the propionylated H2A 4-11 peptide.
The masses of the observed b- and y-type fragment ions are assigned to their corresponding m/z
peaks in the spectrum and are also underlined with the sequence. The asterisks denote fragment
ions that are shifted lower in mass by 14 amu, indicating the presence of in vivo singlyacetylated species. For this analysis, histone H2A was purified from HL60 cells, lysines were
derivatized with propionic anhydride, and H2A peptides were generated with trypsin. H2A
peptides were gradient-eluted via nanoflow-HPLC and mass analyzed with an LTQ-FT mass
spectrometer.
B. CAD mass spectrum of the [M+2H]2+ histone H2A 12-17 peptide. Shown is a mixed spectrum
of two single-acetylated species with the same sequence but with different sites of acetylation.
The MS/MS data indicate acetylation on K13 and K15. The amino acid sequence is shown above
the spectrum, and the masses associated with the sequence correspond to the expected b- and
y-type fragment ions for the propionylated H2A 12-17 peptide. The masses of the observed band y-type fragment ions are assigned as in (A). For this analysis, histone H2A was purified,
derivatized, trypsin digested, and gradient-eluted as in C. CAD mass spectrum of the [M+2H]2+
histone H2A 122-129 peptide. Shown is is a mixed spectrum of three mono-acetylated species
with the same sequence but with different sites of acetylation. The MS/MS data indicate
acetylation on K125, K127, and K129. The amino acid sequence is shown above the spectrum,
and the masses associated with the sequence correspond to the expected singly-charged b- and
y-type fragment ions for the fully deutero-acetylated H2A 122-129 peptide. The masses of the
observed b- and y-type fragment ions are assigned to their corresponding m/z peaks in the
spectrum and are also underlined with the sequence. The asterisks denote fragment ions that are
shifted lower in mass by 3 amu, indicating the presence of in vivo (non-deutero) monoacetylated species. For this analysis, histone H2A was purified from HL60 cells, digested with
GluC, derivatized with deutero succinimido acetate to increase hydrophobicity of the 122-129
H2A peptide, and H2A peptides were gradient-eluted via nanoflow-HPLC and mass analyzed with
an LTQ Orbitrap mass spectrometer. To obtain this spectrum, the precursor ion, m/z 534.1, was
targeted for isolation with a 3 amu window and fragmented via CAD. Image and text provided by
Kristie Rose, Donald Hunt lab, UVA (Charlottesville,VA)
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Appendix Figure 3. MS validation of acetylation sites in budding yeast proteins
Eaf7, Sir3, and Spt6.
Identification of lysine acetylated peptides in Eaf7,Sir3,and Spt6 by LC/MS/MS. The labels b
and y designate the N- and C-terminal fragments, respectively, of the peptide produced by
breakage at the peptide bond in the mass spectrometer. The number represents the
number of N- or C-terminal residues present in the peptide fragment. The superscripts 0, ∗
mean water or ammonia loss, respectively
A.Eaf7K343
B.Sir3K3
C.Spt6K319, Spt6K773, Spt6K958, and Spt6K1238
Images and data provided by Yingming Zhao, UT Southwestern Medical Center (Dallas, TX)
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Appendix Figure 4 MS validation of acetylation sites in WT and A15K mutant strain
LC/MS/MS spectra displaying H3K9ac and H3K14 ac. Figures supplied by Ben Garcia
displaying the WT (H3K9-17) peptide and H3A15K (H3K9-17) spectrum. (Images and data
provided by Ben Garcia, Princeton University (Princeton, NJ). H3K36 methylation data under
A15K mutation and G13V mass spectra image is presently unavailable, but quantitative data
presented in Chapter 3.
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